{"gene":"DLX5","run_date":"2026-06-09T23:54:42","timeline":{"discoveries":[{"year":2004,"finding":"MeCP2 mediates formation of a silent-chromatin loop at the Dlx5-Dlx6 locus by recruiting histone deacetylase 1 and promoting repressive histone methylation at Lys9, thereby suppressing Dlx5 transcription; loss of MeCP2 abolishes this loop and increases Dlx5-Dlx6 expression approximately two-fold in mouse brain.","method":"Chromatin immunoprecipitation combined loop assays, ChIP for HDAC1 and H3K9 methylation, Mecp2-null mouse brains","journal":"Nature genetics","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal ChIP-loop assays with multiple chromatin marks, validated in Mecp2-null mouse brain, multiple orthogonal methods in one study","pmids":["15608638"],"is_preprint":false},{"year":1999,"finding":"Targeted null mutation of Dlx5 in mice causes craniofacial abnormalities (derivatives of branchial arches 1–4), severe malformations of the vestibular organ, delayed ossification of the skull roof, and abnormal osteogenesis, establishing independent roles for Dlx5 in branchial arch patterning, vestibular morphogenesis, and osteoblast differentiation.","method":"Gene targeting (Dlx5 null allele replacing exons I and II with lacZ), phenotypic analysis of homozygous mutant mice","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean loss-of-function with specific phenotypic readouts, independently replicated (PMID 10433912)","pmids":["10433909","10433912"],"is_preprint":false},{"year":2003,"finding":"BMP-2 specifically and immediately induces Dlx5 expression (independent of new protein synthesis), and Dlx5 is an indispensable upstream mediator of BMP-2-induced Runx2 expression and osteoblast differentiation; TGF-β1 opposes this pathway by inducing AP-1, which suppresses Dlx5 expression.","method":"Cycloheximide treatment, antisense Dlx5 blocking, overexpression assays in C2C12 cells, BMP-2/TGF-β1 treatment","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal approaches (cycloheximide, antisense, overexpression), replicated across subsequent studies","pmids":["12815054"],"is_preprint":false},{"year":2003,"finding":"BMP-2-induced Osterix expression requires Dlx5 as an obligatory upstream mediator; antisense blocking of Dlx5 completely abrogates BMP-2-induced Osterix expression, whereas Runx2 overexpression alone is insufficient to induce Osterix in myogenic cells.","method":"Antisense Dlx5 blocking, Runx2 null cells, Runx2 overexpression in C2C12, BMP-2 treatment","journal":"Biochemical and biophysical research communications","confidence":"High","confidence_rationale":"Tier 2 / Strong — antisense loss-of-function with defined molecular readout, replicated in subsequent study (PMID 18056716)","pmids":["12963046"],"is_preprint":false},{"year":2007,"finding":"Dlx5 binds to homeodomain sequences in the proximal Osterix promoter both in vitro and in vivo. Additionally, Dlx5 is a direct substrate of p38 MAPK, which phosphorylates Dlx5 at Ser-34 and Ser-217; this phosphorylation increases the transactivation potential of Dlx5 and enhances Osterix expression.","method":"In vitro kinase assay, in vivo phosphorylation assay, EMSA, ChIP, site-directed mutagenesis of phosphorylation sites, Dlx5 overexpression/knockdown","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro kinase assay plus mutagenesis of phosphorylation sites plus ChIP binding validation, single lab with multiple orthogonal methods","pmids":["18056716"],"is_preprint":false},{"year":2005,"finding":"Dlx5 specifically transactivates the Runx2 type II (P1 distal promoter) by directly binding to three homeodomain-response elements between -756 and -342 bp of the P1 promoter, as confirmed by gel mobility shift assay and site-directed mutagenesis; Msx2 antagonizes this by competing for the same elements.","method":"Runx2 promoter deletion analysis, gel mobility shift assay (EMSA), site-directed mutagenesis, overexpression of Dlx5 and Msx2, in situ hybridization in developing cranial vault","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — EMSA plus mutagenesis plus deletion analysis, single lab with multiple orthogonal methods","pmids":["16115867"],"is_preprint":false},{"year":2004,"finding":"Dlx5 directly binds to a cis-acting homeodomain element in the alkaline phosphatase (ALP) promoter to stimulate ALP expression independently of Runx2; Msx2 competes with Dlx5 for this same element to repress ALP transcription.","method":"EMSA, site-directed mutagenesis, ALP promoter reporter assays, Runx2-null cell studies, Dlx5/Msx2 overexpression","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — EMSA plus mutagenesis plus functional promoter assays, single lab with multiple orthogonal methods","pmids":["15383550"],"is_preprint":false},{"year":1998,"finding":"Dlx5 reverses Msx2-mediated repression of the osteocalcin promoter by forming heterodimers with Msx2 via residues 127–143 of Dlx5; intrinsic DNA binding by Dlx5 is not required for this de-repression, which instead involves abrogating Msx2 inhibition of the OCFREB transcription factor.","method":"Far-Western blot (protein-protein interaction), transient cotransfection reporter assays, deletion/structure-function analysis, EMSA","journal":"Biochemistry","confidence":"High","confidence_rationale":"Tier 1-2 / Moderate — far-Western direct binding plus mutagenesis plus functional reporter assays, single lab with multiple orthogonal methods","pmids":["9819228"],"is_preprint":false},{"year":2001,"finding":"Dlx5 interferes with the ability of Msx2 to interact with Runx2 and to repress Runx2 transcriptional activity; the craniosynostosis-associated Msx2 P148H mutant retains ability to bind and repress Runx2 but is resistant to Dlx5 regulation.","method":"Co-immunoprecipitation, transcriptional reporter assays, overexpression of Dlx5 and Msx2 mutants in C2C12 cells","journal":"Genes to cells : devoted to molecular & cellular mechanisms","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — reciprocal Co-IP plus functional reporter assay, single lab","pmids":["11683913"],"is_preprint":false},{"year":2004,"finding":"Chromatin immunoprecipitation in osteoblasts revealed a sequential switch in homeodomain protein occupancy at the osteocalcin gene promoter: Msx2 occupies the repressed promoter in proliferating osteoblasts, then Dlx3 and Dlx5 are recruited postproliferatively to activate transcription, with Dlx5 occupancy increasing over Dlx3 at the mineralization stage; Dlx5 occupies the OC promoter coincident with increased RNA polymerase II.","method":"Chromatin immunoprecipitation (ChIP) assays, RNA interference knockdown of Dlx3, reporter assays, Dlx3-Runx2 protein-protein interaction mapping","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 / Moderate — ChIP assays with multiple antibodies plus RNAi plus protein interaction mapping, single lab with multiple orthogonal methods","pmids":["15456894"],"is_preprint":false},{"year":2002,"finding":"Dlxin-1, a novel MAGE/necdin-related protein, physically binds Dlx5 (also Dlx7 and Msx2) and activates the transcriptional function of Dlx5 in reporter assays.","method":"Yeast two-hybrid screening, GST pull-down, co-immunoprecipitation, reporter gene assays","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — yeast two-hybrid plus GST pulldown plus Co-IP plus functional reporter, single lab","pmids":["11084035"],"is_preprint":false},{"year":2002,"finding":"The RING finger E3 ubiquitin ligase Praja1 binds Dlxin-1 (a Dlx5-interacting protein) and promotes its ubiquitin-dependent proteasomal degradation, thereby down-regulating Dlx5-dependent transcriptional activity; a RING finger mutant of Praja1 lacks these effects.","method":"Yeast two-hybrid, GST pull-down, co-immunoprecipitation, in vivo ubiquitination assay, proteasome inhibitor treatment, GAL4-dependent transcription reporter assay, RING finger mutagenesis","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1-2 / Moderate — in vivo ubiquitination assay plus domain mutagenesis plus multiple binding assays plus functional reporter, single lab with multiple orthogonal methods","pmids":["11959851"],"is_preprint":false},{"year":2002,"finding":"Combined targeted inactivation of Dlx5 and Dlx6 results in homeotic-like transformation of the lower jaw into an upper jaw structure, demonstrating that Dlx5/6 specify mandibular (lower jaw) identity in the first pharyngeal arch.","method":"Double knockout mice (Dlx5 and Dlx6 null alleles), skeletal morphological analysis","journal":"Genesis (New York, N.Y. : 2000)","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean double loss-of-function with specific morphogenetic readout, replicated in subsequent studies","pmids":["12434331"],"is_preprint":false},{"year":2002,"finding":"Combined null mutation of Dlx5 and Dlx6 causes severe craniofacial, axial, and appendicular skeletal abnormalities including split-hand/split-foot malformation (ectrodactyly); transgenic overexpression of Dlx5 specifically in the apical ectodermal ridge of Dlx5/6 null mice fully rescues limb outgrowth defects.","method":"Double knockout mice, spatiotemporal transgenic rescue, skeletal analysis","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 2 / Strong — double knockout plus transgenic rescue, clean epistasis, replicated findings","pmids":["12000792"],"is_preprint":false},{"year":2002,"finding":"Dlx5 is a positive regulator of chondrocyte maturation; retroviral misexpression of Dlx5 in the chick limb promotes conversion of immature proliferating chondrocytes into hypertrophying chondrocytes, expands type X collagen and osteopontin expression domains, and reduces chondrocyte proliferation.","method":"Retroviral misexpression in chick limb in vivo, histological analysis, molecular marker analysis (type X collagen, osteopontin)","journal":"Developmental biology","confidence":"High","confidence_rationale":"Tier 2 / Moderate — in vivo retroviral gain-of-function with multiple molecular and histological readouts, consistent with Dlx5 null limb phenotype","pmids":["12482714"],"is_preprint":false},{"year":2009,"finding":"Dlx5 is a cell-autonomous regulator of chondrocyte hypertrophy; Col2a1-Dlx5 transgenic mice with Dlx5 restricted specifically to chondrocytes (not perichondrium) display accelerated hypertrophy and mineralization, and this transgene rescues chondrocyte differentiation defects in Dlx5/6 null mice.","method":"Chondrocyte-specific transgenic expression (Col2a1-Dlx5), rescue of Dlx5/6 null phenotype, histological analysis","journal":"PloS one","confidence":"High","confidence_rationale":"Tier 2 / Moderate — cell-type-specific transgenic expression plus null rescue, establishes cell autonomy","pmids":["19956613"],"is_preprint":false},{"year":2002,"finding":"The Dlx5 homeobox gene is essential for vestibular morphogenesis; Dlx5 null mice lack semicircular canals and show shortened endolymphatic duct, and this is accompanied by drastically reduced BMP4 expression in the otic vesicle, placing Bmp4 downstream of Dlx5 in the vestibular development pathway.","method":"Dlx5 null mouse analysis, in situ hybridization for Bmp4, Nkx5.1, Pax2, Lfng; immunostaining for sensory markers","journal":"Developmental biology","confidence":"High","confidence_rationale":"Tier 2 / Moderate — loss-of-function with specific molecular pathway readout, replicated across two independent Dlx5 null studies","pmids":["12142028"],"is_preprint":false},{"year":2010,"finding":"Loss of either Dlx5 alone or Dlx5&6 together preferentially reduces the number of mature parvalbumin-positive cortical interneurons when mutant immature interneurons are transplanted into wild-type brains, demonstrating a cell-autonomous requirement for Dlx5 in development of parvalbumin-positive interneurons; remaining PV+ interneurons show increased dendritic branching.","method":"Cell transplantation of mutant immature interneurons into wild-type brain, conditional Dlx5/6 deletion, electrophysiology, immunohistochemistry for PV/calretinin/somatostatin","journal":"The Journal of neuroscience : the official journal of the Society for Neuroscience","confidence":"High","confidence_rationale":"Tier 2 / Moderate — cell transplantation assay establishes cell autonomy with defined cellular phenotype","pmids":["20392955"],"is_preprint":false},{"year":2010,"finding":"DLX5 directly binds the IRS-2 promoter and transcriptionally activates IRS-2, which in turn sustains AKT phosphorylation; stable knockdown of DLX5 reduces IRS-2 expression, decreases AKT signaling, and inhibits ovarian cancer cell proliferation, while constitutively active AKT rescues this effect.","method":"ChIP of DLX5 binding to IRS-2 promoter, shRNA knockdown, constitutively active AKT rescue, luciferase reporter assay, xenograft tumor assay","journal":"Cancer research","confidence":"High","confidence_rationale":"Tier 2 / Moderate — ChIP direct binding plus functional rescue experiments plus in vivo xenograft, single lab with multiple orthogonal methods","pmids":["21045156"],"is_preprint":false},{"year":2009,"finding":"DLX5 directly binds two sites in the MYC promoter (shown by EMSA and ChIP) and transcriptionally activates MYC in a dose-dependent manner; knockdown of DLX5 in lung cancer cells reduces MYC expression and proliferation, which is rescued by MYC overexpression.","method":"Luciferase promoter assay, EMSA, ChIP, DLX5 overexpression/knockdown, rescue by MYC overexpression","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Moderate — EMSA plus ChIP plus functional rescue, single lab with multiple orthogonal methods","pmids":["19497851"],"is_preprint":false},{"year":2009,"finding":"Loss of Dlx5 in the olfactory epithelium results in olfactory receptor neurons that form normally but fail to generate axons that innervate the olfactory bulb; additionally, Dlx5 has a cell-autonomous effect on neural progenitor ability to produce olfactory bulb local circuit neurons (granule cells more severely affected than periglomerular cells).","method":"Dlx5 null mouse analysis, transplantation of Dlx5-/- olfactory bulbs into wild-type neonates, histological and immunochemical characterization","journal":"The Journal of neuroscience : the official journal of the Society for Neuroscience","confidence":"High","confidence_rationale":"Tier 2 / Moderate — transplantation assay establishes cell autonomy, clean loss-of-function with specific cellular readouts","pmids":["12533617"],"is_preprint":false},{"year":2008,"finding":"Dlx5 null osteoblasts show reduced proliferation and differentiation, reduced Runx2/Osx/Osteocalcin/Bone Sialoprotein expression, and a higher RANKL/OPG ratio; Dlx5-/- osteoblasts induce greater osteoclast formation in spleen cultures, establishing that Dlx5-expressing osteoblasts indirectly control osteoclast activity (osteoblast-osteoclast coupling).","method":"Dlx5 null mouse embryo femur analysis, osteoblast culture, spleen co-culture osteoclast assay, RANKL/OPG expression measurement","journal":"The American journal of pathology","confidence":"High","confidence_rationale":"Tier 2 / Moderate — loss-of-function with multiple molecular and cellular readouts plus ex vivo functional assay","pmids":["18669617"],"is_preprint":false},{"year":2009,"finding":"Calmodulin-dependent kinase II (CaMKII) phosphorylates Dlx5, increases Dlx5 protein stability, and enhances its osteoblastogenic transactivation activity; conversely, the CaMKII inhibitor KN-93 decreases osteogenic and transactivation activities of Dlx5.","method":"In vitro kinase assay, co-transfection with CaMKII, reporter assay, CaMKII inhibitor (KN-93) treatment","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 1-2 / Weak — in vitro kinase assay plus functional reporter, single lab, single paper","pmids":["19393622"],"is_preprint":false},{"year":2000,"finding":"A highly conserved intergenic enhancer (I56i) between Dlx5 and Dlx6 is activated by DLX proteins binding directly to it; Dlx1/2 mutant mice show drastically reduced enhancer activity and reduced Dlx5/6 expression, establishing a cross-regulatory loop where Dlx1/2 drive Dlx5/6 expression through this enhancer.","method":"Reporter transgene in transgenic mice and zebrafish, cotransfection assays, DNA-protein binding experiments, analysis in Dlx1/2 double mutant mice","journal":"The Journal of neuroscience : the official journal of the Society for Neuroscience","confidence":"High","confidence_rationale":"Tier 2 / Strong — transgenic reporter in two species plus direct DNA-protein binding plus genetic epistasis in Dlx1/2 null mice","pmids":["10632600"],"is_preprint":false},{"year":2014,"finding":"Dlx5 and Mef2c directly bind a 343-bp osteoblast-specific enhancer ~30 kb upstream of the Runx2 distal promoter; mutation of their binding sites abolishes osteoblast-specific Runx2 enhancer activity in vivo, while other factors (Tcf7, Ctnnb1, Sp7, Smad1, Sox6) are recruited via protein-protein interaction to form an enhanceosome.","method":"BAC-GFP reporter mice, serial deletion analysis, ChIP in primary osteoblasts, histone modification analysis, mutagenesis of binding sites in transgenic mice","journal":"Journal of bone and mineral research","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — ChIP plus in vivo binding site mutagenesis in transgenic mice, multiple orthogonal methods","pmids":["24692107"],"is_preprint":false},{"year":2011,"finding":"Dlx5 directly promotes transcription of Fgf7 in palatal mesenchyme; loss of Dlx5 leads to Fgf7 downregulation and expanded Shh signaling to the nasal side, while exogenous Fgf7 inhibits Shh signaling and reverses CNC cell proliferation rescue in Msx1/Dlx5 double knockout palates.","method":"Dlx5 null mice, Msx1/Dlx5 double knockout mice, exogenous Fgf7 treatment of palatal mesenchyme cultures, Shh expression analysis","journal":"Development (Cambridge, England)","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — double knockout epistasis plus rescue experiment, single lab","pmids":["19934017"],"is_preprint":false},{"year":2011,"finding":"Hand2 establishes a negative-feedback loop in the distal mandibular arch: Dlx5/6 induce Hand2, and Hand2 subsequently represses Dlx5/6 expression in distal arch ectomesenchyme; failure to repress Dlx5/6 results in upregulation of Runx2, aberrant bone formation, and failure of tongue morphogenesis (aglossia).","method":"Hand2 conditional knockout mice, in situ hybridization for Dlx5/6/Hand2/Runx2, histological analysis of mandibular arch","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 2 / Moderate — conditional knockout with defined epistasis (Dlx5/6→Hand2→Dlx5/6 negative feedback), multiple molecular readouts","pmids":["21558373"],"is_preprint":false},{"year":2014,"finding":"DLX5 targets the FGF8 locus directly and activates FGF8 expression; FGF8 in turn counteracts Pin1-ΔNp63α interaction, preventing Pin1-mediated proteasomal degradation of p63; p63 SHFM/EEC mutant proteins are resistant to Pin1 action, establishing a DLX5-FGF8-Pin1-p63 regulatory loop in AER stratification.","method":"ChIP for DLX5 binding at FGF8 locus, in vitro Pin1-p63 interaction assays, Pin1 null mouse analysis, proteasome inhibitor studies, SHFM/EEC p63 mutant analysis","journal":"Human molecular genetics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP plus in vitro interaction plus mutant protein analysis, single lab","pmids":["24569166"],"is_preprint":false},{"year":2011,"finding":"Chromatin immunoprecipitation confirmed that Dlx5 directly binds the promoters of at least seven genes in the inner ear (Atbf1, Bmper, Large, Lrrtm1, Msx1, Ebf1, and Lhx1), with Bmper and Lrrtm1 upregulated by Dlx5 overexpression, placing Bmp signaling downstream of Dlx5 in the inner ear.","method":"Gene expression profiling of WT vs. Dlx5 null otic vesicles, ChIP with Dlx5 antibody in Dlx5-overexpressing cell line, bioinformatic promoter analysis","journal":"Human molecular genetics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP confirming direct binding plus expression change in overexpression cell line, single lab","pmids":["21227998"],"is_preprint":false},{"year":2004,"finding":"Neural stem cells from Dlx5-null newborn mice have severely reduced capacity to generate neurons in vitro; forced re-expression of Dlx5 in mutant NSCs fully restores neuronogenic potential, demonstrating a cell-autonomous requirement for Dlx5 in postnatal neurogenesis.","method":"Neural stem cell cultures from Dlx5 null mice, forced Dlx5 expression rescue, differentiation assays","journal":"Molecular and cellular neurosciences","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — loss-of-function plus rescue in defined cell culture system, single lab","pmids":["14962748"],"is_preprint":false},{"year":2010,"finding":"AMPK activation (via metformin/AICAR) stimulates osteoblast differentiation through a Smad1/5/8-Dlx5-Runx2 signaling cascade; siRNA knockdown of Dlx5 suppresses metformin-induced Runx2 expression, and dominant-negative AMPK blocks Dlx5 induction.","method":"AMPK activators/inhibitors, DN-AMPK expression, Dlx5 siRNA knockdown, Runx2-Luc reporter assay, BRE-Luc reporter assay","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — siRNA plus reporter assays plus pharmacological epistasis, single lab, single paper","pmids":["21187071"],"is_preprint":false},{"year":2018,"finding":"STAT5A negatively regulates Dlx5 expression; STAT5A deletion in mice results in increased trabecular and cortical bone mass, enhanced Dlx5 levels, and increased osteogenesis of BMSCs, with prevention of age-related bone loss.","method":"STAT5A conditional knockout mice, siRNA knockdown of STAT5A in hBMSCs, in vivo fracture model, micro-CT bone analysis","journal":"Cell death & disease","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vivo knockout plus in vitro knockdown with defined molecular and phenotypic readouts, single lab","pmids":["30429452"],"is_preprint":false},{"year":2018,"finding":"cAMP/PKA signaling suppresses Dlx5 transcription via sequential activation of CREB and then C/EBPβ; C/EBPβ directly binds a specific site (-517 to -510 bp, site-1) in the Dlx5 promoter to repress its transcription during adipogenic differentiation.","method":"cAMP/PKA activators, forced CREB and C/EBPβ expression, siRNA knockdown of C/EBPβ, luciferase promoter assays, ChIP for C/EBPβ at Dlx5 promoter","journal":"International journal of molecular sciences","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP confirming direct binding plus promoter mutagenesis plus epistasis experiments, single lab","pmids":["30322210"],"is_preprint":false},{"year":2016,"finding":"Dlx5 and Dlx6 regulate Msx2 expression cell-autonomously in AER cells and limb mesoderm; in the anterior limb mesoderm, a non-cell-autonomous Msx-Dlx regulatory loop involves BMP molecules through the AER; ChIP analysis confirmed Dlx5/6 regulatory interactions at the Msx2 locus.","method":"Triple knockout mice (Msx1/Dlx5/Dlx6 and Msx2/Dlx5/Dlx6), qPCR, ChIP, bioinformatic analysis","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP plus triple-mutant genetic epistasis, single lab","pmids":["23382810"],"is_preprint":false},{"year":2017,"finding":"Dlx5 in CNC cells regulates FGF10 pathway activity; loss of Dlx5 reduces FGF10 signaling and leads to altered proliferation/apoptosis of CNC and muscle progenitor cells in the soft palate; activation of FGF10 signaling rescues CNC cell proliferation and myogenic differentiation in Dlx5 mutant mice.","method":"Dlx5 conditional knockout in NCCs (Wnt1-Cre), FGF10 pathway analysis, exogenous FGF10 rescue experiment, lineage tracing","journal":"Development (Cambridge, England)","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — conditional knockout plus rescue experiment, single lab with defined molecular pathway","pmids":["28982687"],"is_preprint":false},{"year":2021,"finding":"DLX5 cooperates with TP63 to regulate ~2000 enhancers and promoters in squamous cell carcinoma; DLX5 transcriptional activation is directly mediated by SOX2 at the bivalent DLX5 promoter; DLX5 silencing substantially inhibits SCC cell viability in vitro and in vivo.","method":"ELMER computational analysis, ChIP-seq for DLX5 and TP63, SOX2 ChIP, shRNA knockdown in vitro and xenograft in vivo, bisulfite sequencing for promoter methylation","journal":"Nucleic acids research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP-seq plus functional knockdown in vitro and in vivo, single lab","pmids":["34370013"],"is_preprint":false},{"year":2023,"finding":"DLX5 directly binds the Col10a1 cis-enhancer to promote Col10a1 transcription and chondrocyte hypertrophy; forced DLX5 expression in hypertrophic chondrocytes upregulates RUNX2, suggesting cooperative regulation of Col10a1 by DLX5 and RUNX2 through adjacent binding sites on the enhancer.","method":"Dual-luciferase reporter assay, ChIP assay with DLX5 antibody, Dlx5 overexpression and knockdown in MCT and ATDC5 cells, murine OA model","journal":"Genes & diseases","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP confirming direct binding plus luciferase assay plus gain/loss-of-function, single lab","pmids":["37492739"],"is_preprint":false},{"year":1998,"finding":"An alternative Dlx5 transcript (deltaDlx5) encodes a truncated protein lacking the homeodomain; unlike full-length DLX5, deltaDLX5 is deficient in DNA-binding activity and does not interact with the homeoprotein partner MSX1.","method":"RT-PCR cloning, in vitro DNA-binding assay, co-immunoprecipitation/interaction assays","journal":"The Journal of neuroscience : the official journal of the Society for Neuroscience","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — direct comparison of protein activities, single lab, single paper","pmids":["9763476"],"is_preprint":false},{"year":2020,"finding":"DLX5 and HOXC8 form a protein complex and co-operatively repress LINC01013 lncRNA by directly binding its promoter (ChIP-confirmed); DLX5/HOXC8-mediated repression of LINC01013 enhances chondrogenic differentiation of stem cells from apical papilla.","method":"Co-immunoprecipitation for DLX5-HOXC8 complex, ChIP assay for promoter binding, LINC01013 knockdown, pellet culture and in vivo cartilage defect model","journal":"Stem cell research & therapy","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP plus ChIP plus functional in vivo rescue, single lab","pmids":["32631410"],"is_preprint":false},{"year":2011,"finding":"Allelic reduction of Dlx5 and Dlx6 in mouse ovary results in POI-like phenotype with reduced fertility and early follicular exhaustion; a reciprocal regulation exists between Dlx5/6 and Foxl2 in granulosa cells, and Dlx5/6 reduction leads to upregulation of Foxl2, with both factors having opposing effects on StAR expression.","method":"Dlx5/6 hypomorph mice, granulosa cell line transfection, StAR and Foxl2 expression analysis","journal":"Human molecular genetics","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — genetic model plus cell line transfection, single lab, single paper","pmids":["21505076"],"is_preprint":false},{"year":2015,"finding":"Dlx5 is expressed by olfactory receptor neurons and controls miR-9 and miR-200 class miRNA levels in the olfactory epithelium; in zebrafish, depletion of miR-9 and miR-200 causes delayed ORN differentiation, altered axonal targeting, and altered GnRH neuron genesis, with miR-9/-200 negatively controlling Foxg1 mRNA.","method":"miRNA expression profiling in Dlx5 null olfactory epithelium, miR-9/200 morpholino depletion in zebrafish reporter embryos, foxg1 mRNA overexpression in zebrafish","journal":"Molecular and cellular neurosciences","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — loss-of-function in mouse plus functional validation in zebrafish, two organisms, single lab","pmids":["25937343"],"is_preprint":false},{"year":2010,"finding":"A single nucleotide polymorphism in the ultraconserved Dlx5/6 intergenic enhancer I56i (found in an autistic proband) reduces DLX protein binding affinity in vitro and reduces transcriptional activation of the enhancer by Dlx proteins; affinity purification identified GTF2I as a novel regulator binding the I56i element.","method":"Transgenic enhancer reporter mice, in vitro DNA-protein binding affinity assay, affinity purification, electrophoretic mobility shift assay","journal":"Development (Cambridge, England)","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — transgenic reporter plus in vitro binding plus affinity purification, single lab","pmids":["20702565"],"is_preprint":false}],"current_model":"DLX5 is a homeodomain transcription factor that functions as a central regulator of osteoblast, chondrocyte, neural, and craniofacial development: it is directly induced by BMP-2 signaling (immediately, without requiring new protein synthesis) and acts upstream of Runx2 type II (via direct binding to P1 promoter homeodomain elements), Osterix (via direct binding to the Osterix proximal promoter), and alkaline phosphatase (via a cis-acting homeodomain element in the ALP promoter); its transcriptional activity is modulated post-translationally by p38 MAPK phosphorylation at Ser-34/Ser-217 (enhancing activity) and by CaMKII phosphorylation (increasing protein stability and transactivation); it forms inhibitory heterodimers with MSX2 (requiring residues 127–143) to relieve MSX2 repression of osteocalcin transcription; the Dlxin-1 co-activator and the E3 ubiquitin ligase Praja1 (which degrades Dlxin-1) further tune DLX5 transcriptional output; in the nervous system, DLX5 is required cell-autonomously for parvalbumin-positive cortical interneuron development and postnatal neurogenesis; in jaw development, DLX5/6 specify mandibular identity in neural crest cells and are themselves regulated by a Hand2 negative-feedback loop; DLX5 drives MYC and IRS-2 transcription in cancer contexts; and long-range cis-regulatory enhancers (including sequences within and near DYNC1I1) control tissue-specific DLX5 expression, with disruption of these enhancers underlying split-hand/foot malformation."},"narrative":{"mechanistic_narrative":"DLX5 is a homeodomain transcription factor that serves as a central effector of skeletal, craniofacial, and neural development, transducing BMP signaling into osteogenic and patterning gene programs [PMID:12815054, PMID:10433909, PMID:10433912]. In the osteoblast lineage, BMP-2 immediately and protein-synthesis-independently induces Dlx5, which acts as an obligatory upstream mediator of both Runx2 and Osterix and is itself required for osteoblast differentiation [PMID:12815054, PMID:12963046]. DLX5 exerts this control by directly binding homeodomain elements: three response elements in the Runx2 type II (P1) promoter, the proximal Osterix promoter, a cis-element in the alkaline phosphatase promoter, and an osteoblast-specific Runx2 enhancer where it cooperates with Mef2c to nucleate an enhanceosome [PMID:16115867, PMID:18056716, PMID:15383550, PMID:24692107]. At the osteocalcin promoter DLX5 antagonizes MSX2-mediated repression, both by competing for shared homeodomain elements and by forming inhibitory heterodimers with MSX2 through residues 127–143, and a developmental switch recruits DLX5 to activate the gene postproliferatively [PMID:16115867, PMID:15383550, PMID:9819228, PMID:15456894]. DLX5 transcriptional output is tuned post-translationally by p38 MAPK phosphorylation at Ser-34/Ser-217 and by CaMKII, which enhance transactivation and stability, and by the Dlxin-1 co-activator whose abundance is controlled by the E3 ligase Praja1 [PMID:18056716, PMID:19393622, PMID:11084035, PMID:11959851]. In craniofacial development DLX5/6 specify mandibular identity, regulate chondrocyte hypertrophy cell-autonomously, and operate within Hand2 negative-feedback and FGF-mediated mesenchymal circuits [PMID:12434331, PMID:19956613, PMID:21558373, PMID:28982687]. Long-range DLX5/6 intergenic enhancers (I56i) are bound and cross-activated by DLX proteins, and combined Dlx5/6 loss produces split-hand/split-foot malformation with limb defects rescuable by AER-restricted Dlx5 [PMID:10632600, PMID:12000792]. In the nervous system DLX5 is cell-autonomously required for parvalbumin-positive cortical interneuron development, postnatal neurogenesis, and olfactory neuron axon targeting [PMID:20392955, PMID:14962748, PMID:12533617]. In cancer, DLX5 directly activates MYC and IRS-2 to drive proliferation and AKT signaling [PMID:19497851, PMID:21045156].","teleology":[{"year":1998,"claim":"Established that DLX5 functions partly through protein-protein interaction rather than solely DNA binding, by showing it heterodimerizes with MSX2 to relieve repression of osteocalcin.","evidence":"Far-Western, deletion/structure-function mapping and reporter assays identifying residues 127–143","pmids":["9819228"],"confidence":"High","gaps":["Did not map the MSX2 interaction surface","OCFREB de-repression mechanism not structurally defined"]},{"year":1999,"claim":"Defined the in vivo requirement for Dlx5, showing it is independently needed for branchial arch patterning, vestibular morphogenesis, and osteoblast differentiation.","evidence":"Dlx5-null mouse with phenotypic analysis, independently replicated","pmids":["10433909","10433912"],"confidence":"High","gaps":["Did not identify direct transcriptional targets underlying each phenotype","Functional redundancy with Dlx6 not resolved"]},{"year":2002,"claim":"Placed Dlx5/6 at the top of jaw and limb identity programs through combinatorial loss-of-function and spatially restricted rescue.","evidence":"Dlx5/6 double-knockout mice with mandibular-to-maxillary transformation and AER-restricted transgenic rescue of limb defects","pmids":["12434331","12000792"],"confidence":"High","gaps":["Direct targets specifying mandibular identity not enumerated","Mechanism of split-hand/foot phenotype not molecularly resolved here"]},{"year":2003,"claim":"Identified Dlx5 as the indispensable, immediate BMP-2 effector upstream of both Runx2 and Osterix, ordering the osteogenic transcription cascade.","evidence":"Cycloheximide, antisense Dlx5 blocking and overexpression in C2C12 cells with BMP-2/TGF-β1 treatment","pmids":["12815054","12963046"],"confidence":"High","gaps":["Did not show direct promoter binding (addressed later)","Mechanism of immediate BMP-2 induction of Dlx5 not defined"]},{"year":2005,"claim":"Demonstrated direct, sequence-specific DLX5 transactivation of Runx2 type II and competitive antagonism by MSX2, providing the cis-regulatory basis for the cascade.","evidence":"Runx2 promoter deletion, EMSA, site-directed mutagenesis of three homeodomain elements, Dlx5/Msx2 overexpression","pmids":["16115867"],"confidence":"High","gaps":["In vivo enhancer context not tested here (later addressed)","Stoichiometry of Dlx5/Msx2 competition not quantified"]},{"year":2007,"claim":"Showed that DLX5 osteogenic activity is gated by signaling, with p38 MAPK directly phosphorylating Ser-34/Ser-217 to boost transactivation and Osterix expression.","evidence":"In vitro/in vivo kinase assays, phosphosite mutagenesis, EMSA and ChIP at Osterix promoter","pmids":["18056716"],"confidence":"High","gaps":["Structural consequence of phosphorylation not defined","Whether CaMKII and p38 act on same residues unknown"]},{"year":2004,"claim":"Revealed a co-activator/degradation module tuning DLX5 output via Dlxin-1 and its turnover, and a chromatin-level repression mechanism at the locus via MeCP2.","evidence":"Y2H/GST/Co-IP and ubiquitination assays for Dlxin-1–Praja1; ChIP-loop assays for MeCP2/HDAC1/H3K9me at the Dlx5–Dlx6 locus in Mecp2-null brain","pmids":["11084035","11959851","15608638"],"confidence":"High","gaps":["Physiological contexts where Dlxin-1/Praja1 set DLX5 levels not defined","Whether MeCP2 silencing operates outside brain unknown"]},{"year":2004,"claim":"Resolved DLX5 as a Runx2-independent activator of differentiation markers and established its cell-autonomous role in postnatal neurogenesis.","evidence":"EMSA/mutagenesis at the ALP promoter in Runx2-null cells; Dlx5-null neural stem cell cultures with re-expression rescue","pmids":["15383550","14962748"],"confidence":"High","gaps":["Downstream neuronal differentiation targets of DLX5 not identified","ALP activation cofactors not defined"]},{"year":2010,"claim":"Extended DLX5 function to interneuron specification and cancer, showing cell-autonomous control of parvalbumin interneurons and direct activation of MYC and IRS-2 in tumors.","evidence":"Interneuron transplantation/conditional deletion; EMSA/ChIP and rescue for MYC (lung) and IRS-2/AKT (ovarian) in tumor models","pmids":["20392955","19497851","21045156"],"confidence":"High","gaps":["How DLX5 is reactivated in cancer not defined here","Interneuron target genes not identified"]},{"year":2014,"claim":"Established the in vivo enhanceosome basis of DLX5-driven osteoblast Runx2 expression and connected DLX5 to AER stratification through an FGF8-Pin1-p63 loop.","evidence":"BAC-GFP reporter mice with binding-site mutagenesis (Dlx5/Mef2c Runx2 enhancer); ChIP and Pin1/p63 interaction analysis for FGF8 loop","pmids":["24692107","24569166"],"confidence":"High","gaps":["Order of enhanceosome assembly not resolved","FGF8-Pin1-p63 loop is single-lab Medium evidence"]},{"year":2011,"claim":"Defined the Hand2 negative-feedback architecture and FGF-mediated mesenchymal circuits through which Dlx5 patterns the mandibular arch and palate.","evidence":"Conditional knockouts and double-knockout epistasis with Fgf7/Fgf10/Shh rescue experiments","pmids":["21558373","19934017","28982687"],"confidence":"Medium","gaps":["Direct vs indirect regulation of some FGF ligands not fully separated","Single-lab epistasis for several circuits"]},{"year":2018,"claim":"Identified upstream repressive inputs (STAT5A, cAMP/PKA-CREB-C/EBPβ) that set Dlx5 levels and bias osteogenic vs adipogenic fate.","evidence":"STAT5A knockout/knockdown with micro-CT; cAMP/PKA epistasis with ChIP for C/EBPβ at the Dlx5 promoter","pmids":["30429452","30322210"],"confidence":"Medium","gaps":["Single-lab studies","Integration of multiple repressive inputs not modeled"]},{"year":2021,"claim":"Showed DLX5 acts within a TP63/SOX2 oncogenic enhancer network in squamous cell carcinoma, broadening its cancer role beyond single-gene activation.","evidence":"ChIP-seq for DLX5/TP63, SOX2 ChIP, bisulfite sequencing, and shRNA knockdown in vitro and in xenografts","pmids":["34370013"],"confidence":"Medium","gaps":["Single-lab study","Mechanism coupling SOX2-driven DLX5 to specific oncogenic outputs not fully defined"]},{"year":null,"claim":"How DLX5's distinct post-translational modifications, cofactor states, and partner choices are integrated to select among osteogenic, chondrogenic, neural, and oncogenic gene programs in a given cell remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No unified model linking phosphorylation state to target selectivity","Genome-wide DLX5 occupancy compared across tissues not established","Structural basis of MSX2/HOXC8 heterodimer specificity unknown"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[2,5,18,19,24]},{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[4,5,6,19,28]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[4,5,9]}],"pathway":[{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[1,12,13,14]},{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[5,6,18,19,24]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[2,3,4,22]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[13,18,19,35]}],"complexes":["Runx2 osteoblast enhanceosome (Dlx5/Mef2c)"],"partners":["MSX2","MEF2C","DLXIN-1","HOXC8","TP63","MSX1"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P56178","full_name":"Homeobox protein DLX-5","aliases":[],"length_aa":289,"mass_kda":31.5,"function":"Transcriptional factor involved in bone development. Acts as an immediate early BMP-responsive transcriptional activator essential for osteoblast differentiation. Stimulates ALPL promoter activity in a RUNX2-independent manner during osteoblast differentiation. Stimulates SP7 promoter activity during osteoblast differentiation. Promotes cell proliferation by up-regulating MYC promoter activity. Involved as a positive regulator of both chondrogenesis and chondrocyte hypertrophy in the endochondral skeleton. Binds to the homeodomain-response element of the ALPL and SP7 promoter. Binds to the MYC promoter. Requires the 5'-TAATTA-3' consensus sequence for DNA-binding","subcellular_location":"Nucleus","url":"https://www.uniprot.org/uniprotkb/P56178/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/DLX5","classification":"Not Classified","n_dependent_lines":18,"n_total_lines":1208,"dependency_fraction":0.014900662251655629},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/DLX5","total_profiled":1310},"omim":[{"mim_id":"621311","title":"DEVELOPMENTAL DYSPLASIA OF THE HIP 4; DDH4","url":"https://www.omim.org/entry/621311"},{"mim_id":"614464","title":"JOUBERT SYNDROME 15; JBTS15","url":"https://www.omim.org/entry/614464"},{"mim_id":"612351","title":"FORKHEAD BOX I3; FOXI3","url":"https://www.omim.org/entry/612351"},{"mim_id":"610523","title":"CENTROSOMAL PROTEIN, 41-KD; CEP41","url":"https://www.omim.org/entry/610523"},{"mim_id":"606359","title":"WINGLESS-TYPE MMTV INTEGRATION SITE FAMILY, MEMBER 3A; WNT3A","url":"https://www.omim.org/entry/606359"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Nucleoplasm","reliability":"Approved"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"endometrium 1","ntpm":13.2},{"tissue":"placenta","ntpm":11.0},{"tissue":"skin 1","ntpm":26.1}],"url":"https://www.proteinatlas.org/search/DLX5"},"hgnc":{"alias_symbol":[],"prev_symbol":[]},"alphafold":{"accession":"P56178","domains":[{"cath_id":"1.10.10.60","chopping":"145-197","consensus_level":"high","plddt":96.9904,"start":145,"end":197}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P56178","model_url":"https://alphafold.ebi.ac.uk/files/AF-P56178-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P56178-F1-predicted_aligned_error_v6.png","plddt_mean":60.69},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=DLX5","jax_strain_url":"https://www.jax.org/strain/search?query=DLX5"},"sequence":{"accession":"P56178","fasta_url":"https://rest.uniprot.org/uniprotkb/P56178.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P56178/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P56178"}},"corpus_meta":[{"pmid":"15608638","id":"PMC_15608638","title":"Loss of silent-chromatin looping and impaired imprinting of DLX5 in Rett syndrome.","date":"2004","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/15608638","citation_count":440,"is_preprint":false},{"pmid":"10433909","id":"PMC_10433909","title":"Craniofacial, vestibular and bone defects in mice lacking the Distal-less-related gene Dlx5.","date":"1999","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/10433909","citation_count":359,"is_preprint":false},{"pmid":"12815054","id":"PMC_12815054","title":"BMP-2-induced Runx2 expression is mediated by Dlx5, and TGF-beta 1 opposes the BMP-2-induced osteoblast differentiation by suppression of Dlx5 expression.","date":"2003","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12815054","citation_count":350,"is_preprint":false},{"pmid":"12000792","id":"PMC_12000792","title":"The Dlx5 and Dlx6 homeobox genes are essential for craniofacial, axial, and appendicular skeletal development.","date":"2002","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/12000792","citation_count":340,"is_preprint":false},{"pmid":"12963046","id":"PMC_12963046","title":"BMP-2-induced Osterix expression is mediated by Dlx5 but is independent of Runx2.","date":"2003","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/12963046","citation_count":331,"is_preprint":false},{"pmid":"10433912","id":"PMC_10433912","title":"Dlx5 regulates regional development of the branchial arches and sensory capsules.","date":"1999","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/10433912","citation_count":288,"is_preprint":false},{"pmid":"10632600","id":"PMC_10632600","title":"A highly conserved enhancer in the Dlx5/Dlx6 intergenic region is the site of cross-regulatory interactions between Dlx genes in the embryonic forebrain.","date":"2000","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/10632600","citation_count":275,"is_preprint":false},{"pmid":"10516593","id":"PMC_10516593","title":"DLX-1, DLX-2, and DLX-5 expression define distinct stages of basal forebrain differentiation.","date":"1999","source":"The Journal of comparative neurology","url":"https://pubmed.ncbi.nlm.nih.gov/10516593","citation_count":237,"is_preprint":false},{"pmid":"15456894","id":"PMC_15456894","title":"Dlx3 transcriptional regulation of osteoblast differentiation: temporal recruitment of Msx2, Dlx3, and Dlx5 homeodomain proteins to chromatin of the osteocalcin gene.","date":"2004","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/15456894","citation_count":230,"is_preprint":false},{"pmid":"18056716","id":"PMC_18056716","title":"BMP-2 induces Osterix expression through up-regulation of Dlx5 and its phosphorylation by p38.","date":"2007","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/18056716","citation_count":185,"is_preprint":false},{"pmid":"16115867","id":"PMC_16115867","title":"Dlx5 specifically regulates Runx2 type II expression by binding to homeodomain-response elements in the Runx2 distal promoter.","date":"2005","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16115867","citation_count":171,"is_preprint":false},{"pmid":"15383550","id":"PMC_15383550","title":"Bone morphogenetic protein-2-induced alkaline phosphatase expression is stimulated by Dlx5 and repressed by Msx2.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15383550","citation_count":163,"is_preprint":false},{"pmid":"10075846","id":"PMC_10075846","title":"A BMP-inducible gene, dlx5, regulates osteoblast differentiation and mesoderm induction.","date":"1999","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/10075846","citation_count":161,"is_preprint":false},{"pmid":"12434331","id":"PMC_12434331","title":"Jaw transformation with gain of symmetry after Dlx5/Dlx6 inactivation: mirror of the past?","date":"2002","source":"Genesis (New York, N.Y. : 2000)","url":"https://pubmed.ncbi.nlm.nih.gov/12434331","citation_count":157,"is_preprint":false},{"pmid":"11683913","id":"PMC_11683913","title":"Regulation of the activity of the transcription factor Runx2 by two homeobox proteins, Msx2 and Dlx5.","date":"2001","source":"Genes to cells : devoted to molecular & cellular mechanisms","url":"https://pubmed.ncbi.nlm.nih.gov/11683913","citation_count":148,"is_preprint":false},{"pmid":"15223343","id":"PMC_15223343","title":"Segregation of lens and olfactory precursors from a common territory: cell sorting and reciprocity of Dlx5 and Pax6 expression.","date":"2004","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/15223343","citation_count":140,"is_preprint":false},{"pmid":"20392955","id":"PMC_20392955","title":"Dlx5 and Dlx6 regulate the development of parvalbumin-expressing cortical interneurons.","date":"2010","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/20392955","citation_count":139,"is_preprint":false},{"pmid":"12812786","id":"PMC_12812786","title":"DLX5 positions the neural crest and preplacode region at the border of the neural plate.","date":"2003","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/12812786","citation_count":122,"is_preprint":false},{"pmid":"9819228","id":"PMC_9819228","title":"Reciprocal regulation of osteocalcin transcription by the homeodomain proteins Msx2 and Dlx5.","date":"1998","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9819228","citation_count":120,"is_preprint":false},{"pmid":"12533617","id":"PMC_12533617","title":"DLX5 regulates development of peripheral and central components of the olfactory system.","date":"2003","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/12533617","citation_count":110,"is_preprint":false},{"pmid":"24692107","id":"PMC_24692107","title":"Dlx5 and mef2 regulate a novel runx2 enhancer for osteoblast-specific expression.","date":"2014","source":"Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research","url":"https://pubmed.ncbi.nlm.nih.gov/24692107","citation_count":102,"is_preprint":false},{"pmid":"21205918","id":"PMC_21205918","title":"Tumor necrosis factor-α accelerates the calcification of human aortic valve interstitial cells obtained from patients with calcific aortic valve stenosis via the BMP2-Dlx5 pathway.","date":"2010","source":"The Journal of pharmacology and experimental therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/21205918","citation_count":100,"is_preprint":false},{"pmid":"11959851","id":"PMC_11959851","title":"A RING finger protein Praja1 regulates Dlx5-dependent transcription through its ubiquitin ligase activity for the Dlx/Msx-interacting MAGE/Necdin family protein, Dlxin-1.","date":"2002","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11959851","citation_count":93,"is_preprint":false},{"pmid":"11084035","id":"PMC_11084035","title":"Dlxin-1, a novel protein that binds Dlx5 and regulates its transcriptional function.","date":"2000","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11084035","citation_count":92,"is_preprint":false},{"pmid":"8541214","id":"PMC_8541214","title":"The expression pattern of the Distal-less homeobox-containing gene Dlx-5 in the developing chick limb bud suggests its involvement in apical ectodermal ridge activity, pattern formation, and cartilage differentiation.","date":"1995","source":"Mechanisms of development","url":"https://pubmed.ncbi.nlm.nih.gov/8541214","citation_count":92,"is_preprint":false},{"pmid":"9763476","id":"PMC_9763476","title":"An early phase of embryonic Dlx5 expression defines the rostral boundary of the neural plate.","date":"1998","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/9763476","citation_count":90,"is_preprint":false},{"pmid":"17335796","id":"PMC_17335796","title":"Dlx5 drives Runx2 expression and osteogenic differentiation in developing cranial suture mesenchyme.","date":"2007","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/17335796","citation_count":89,"is_preprint":false},{"pmid":"18669617","id":"PMC_18669617","title":"Dlx5, a positive regulator of osteoblastogenesis, is essential for osteoblast-osteoclast coupling.","date":"2008","source":"The American journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/18669617","citation_count":89,"is_preprint":false},{"pmid":"12142028","id":"PMC_12142028","title":"The Dlx5 homeobox gene is essential for vestibular morphogenesis in the mouse embryo through a BMP4-mediated pathway.","date":"2002","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/12142028","citation_count":87,"is_preprint":false},{"pmid":"21187071","id":"PMC_21187071","title":"AMP-activated protein kinase (AMPK) positively regulates osteoblast differentiation via induction of Dlx5-dependent Runx2 expression in MC3T3E1 cells.","date":"2010","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/21187071","citation_count":78,"is_preprint":false},{"pmid":"12710966","id":"PMC_12710966","title":"BMP signals regulate Dlx5 during early avian skull development.","date":"2003","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/12710966","citation_count":74,"is_preprint":false},{"pmid":"21558373","id":"PMC_21558373","title":"Downregulation of Dlx5 and Dlx6 expression by Hand2 is essential for initiation of tongue morphogenesis.","date":"2011","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/21558373","citation_count":73,"is_preprint":false},{"pmid":"22121204","id":"PMC_22121204","title":"Identification of a novel DLX5 mutation in a family with autosomal recessive split hand and foot malformation.","date":"2011","source":"Journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/22121204","citation_count":71,"is_preprint":false},{"pmid":"12054155","id":"PMC_12054155","title":"Overexpression of Dlx5 in chicken calvarial cells accelerates osteoblastic differentiation.","date":"2002","source":"Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research","url":"https://pubmed.ncbi.nlm.nih.gov/12054155","citation_count":66,"is_preprint":false},{"pmid":"19934017","id":"PMC_19934017","title":"Indirect modulation of Shh signaling by Dlx5 affects the oral-nasal patterning of palate and rescues cleft palate in Msx1-null mice.","date":"2009","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/19934017","citation_count":66,"is_preprint":false},{"pmid":"12482714","id":"PMC_12482714","title":"Dlx5 is a positive regulator of chondrocyte differentiation during endochondral ossification.","date":"2002","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/12482714","citation_count":64,"is_preprint":false},{"pmid":"11599044","id":"PMC_11599044","title":"Distinct roles for Distal-less genes Dlx3 and Dlx5 in regulating ectodermal development in Xenopus.","date":"2001","source":"Molecular reproduction and development","url":"https://pubmed.ncbi.nlm.nih.gov/11599044","citation_count":62,"is_preprint":false},{"pmid":"12727448","id":"PMC_12727448","title":"The Dlx5 homeodomain gene is essential for olfactory development and connectivity in the mouse.","date":"2003","source":"Molecular and cellular neurosciences","url":"https://pubmed.ncbi.nlm.nih.gov/12727448","citation_count":61,"is_preprint":false},{"pmid":"20702565","id":"PMC_20702565","title":"An SNP in an ultraconserved regulatory element affects Dlx5/Dlx6 regulation in the forebrain.","date":"2010","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/20702565","citation_count":59,"is_preprint":false},{"pmid":"28904069","id":"PMC_28904069","title":"Disturbed Placental Imprinting in Preeclampsia Leads to Altered Expression of DLX5, a Human-Specific Early Trophoblast Marker.","date":"2017","source":"Circulation","url":"https://pubmed.ncbi.nlm.nih.gov/28904069","citation_count":58,"is_preprint":false},{"pmid":"16330189","id":"PMC_16330189","title":"Msx1 and Dlx5 act independently in development of craniofacial skeleton, but converge on the regulation of Bmp signaling in palate formation.","date":"2005","source":"Mechanisms of development","url":"https://pubmed.ncbi.nlm.nih.gov/16330189","citation_count":57,"is_preprint":false},{"pmid":"25870836","id":"PMC_25870836","title":"Different Methylation Patterns of RUNX2, OSX, DLX5 and BSP in Osteoblastic Differentiation of Mesenchymal Stem Cells.","date":"2015","source":"Cell journal","url":"https://pubmed.ncbi.nlm.nih.gov/25870836","citation_count":55,"is_preprint":false},{"pmid":"21045156","id":"PMC_21045156","title":"Upregulation of DLX5 promotes ovarian cancer cell proliferation by enhancing IRS-2-AKT signaling.","date":"2010","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/21045156","citation_count":52,"is_preprint":false},{"pmid":"22914741","id":"PMC_22914741","title":"Functional characterization of tissue-specific enhancers in the DLX5/6 locus.","date":"2012","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/22914741","citation_count":51,"is_preprint":false},{"pmid":"25937343","id":"PMC_25937343","title":"The Dlx5 and Foxg1 transcription factors, linked via miRNA-9 and -200, are required for the development of the olfactory and GnRH system.","date":"2015","source":"Molecular and cellular neurosciences","url":"https://pubmed.ncbi.nlm.nih.gov/25937343","citation_count":50,"is_preprint":false},{"pmid":"18684439","id":"PMC_18684439","title":"TGF-beta mediated Dlx5 signaling plays a crucial role in osteo-chondroprogenitor cell lineage determination during mandible development.","date":"2008","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/18684439","citation_count":50,"is_preprint":false},{"pmid":"14962748","id":"PMC_14962748","title":"Defective neuronogenesis in the absence of Dlx5.","date":"2004","source":"Molecular and cellular neurosciences","url":"https://pubmed.ncbi.nlm.nih.gov/14962748","citation_count":49,"is_preprint":false},{"pmid":"16900517","id":"PMC_16900517","title":"Dlx5 and Dlx6 homeobox genes are required for specification of the mammalian vestibular apparatus.","date":"2006","source":"Genesis (New York, N.Y. : 2000)","url":"https://pubmed.ncbi.nlm.nih.gov/16900517","citation_count":45,"is_preprint":false},{"pmid":"17701895","id":"PMC_17701895","title":"DLX5 and DLX6 expression is biallelic and not modulated by MeCP2 deficiency.","date":"2007","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/17701895","citation_count":44,"is_preprint":false},{"pmid":"14654219","id":"PMC_14654219","title":"Msx1/Bmp4 genetic pathway regulates mammalian alveolar bone formation via induction of Dlx5 and Cbfa1.","date":"2003","source":"Mechanisms of development","url":"https://pubmed.ncbi.nlm.nih.gov/14654219","citation_count":41,"is_preprint":false},{"pmid":"21108812","id":"PMC_21108812","title":"Mutually exclusive expression of DLX2 and DLX5/6 is associated with the metastatic potential of the human breast cancer cell line MDA-MB-231.","date":"2010","source":"BMC cancer","url":"https://pubmed.ncbi.nlm.nih.gov/21108812","citation_count":40,"is_preprint":false},{"pmid":"12895028","id":"PMC_12895028","title":"Dlx5 regulates chondrocyte differentiation at multiple stages.","date":"2003","source":"The International journal of developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/12895028","citation_count":40,"is_preprint":false},{"pmid":"19497851","id":"PMC_19497851","title":"DLX5 (distal-less homeobox 5) promotes tumor cell proliferation by transcriptionally regulating MYC.","date":"2009","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19497851","citation_count":39,"is_preprint":false},{"pmid":"31514171","id":"PMC_31514171","title":"Dlx5 and Dlx6 expression in GABAergic neurons controls behavior, metabolism, healthy aging and lifespan.","date":"2019","source":"Aging","url":"https://pubmed.ncbi.nlm.nih.gov/31514171","citation_count":37,"is_preprint":false},{"pmid":"19707792","id":"PMC_19707792","title":"Deletion of an enhancer near DLX5 and DLX6 in a family with hearing loss, craniofacial defects, and an inv(7)(q21.3q35).","date":"2010","source":"Human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/19707792","citation_count":37,"is_preprint":false},{"pmid":"32631410","id":"PMC_32631410","title":"DLX5 and HOXC8 enhance the chondrogenic differentiation potential of stem cells from apical papilla via LINC01013.","date":"2020","source":"Stem cell research & therapy","url":"https://pubmed.ncbi.nlm.nih.gov/32631410","citation_count":36,"is_preprint":false},{"pmid":"28025541","id":"PMC_28025541","title":"miR-203 and miR-320 Regulate Bone Morphogenetic Protein-2-Induced Osteoblast Differentiation by Targeting Distal-Less Homeobox 5 (Dlx5).","date":"2016","source":"Genes","url":"https://pubmed.ncbi.nlm.nih.gov/28025541","citation_count":35,"is_preprint":false},{"pmid":"24459211","id":"PMC_24459211","title":"Next generation sequencing of chromosomal rearrangements in patients with split-hand/split-foot malformation provides evidence for DYNC1I1 exonic enhancers of DLX5/6 expression in humans.","date":"2014","source":"Journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/24459211","citation_count":35,"is_preprint":false},{"pmid":"24569166","id":"PMC_24569166","title":"DLX5, FGF8 and the Pin1 isomerase control ΔNp63α protein stability during limb development: a regulatory loop at the basis of the SHFM and EEC congenital malformations.","date":"2014","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/24569166","citation_count":34,"is_preprint":false},{"pmid":"24733577","id":"PMC_24733577","title":"MiR-124 inhibits myogenic differentiation of mesenchymal stem cells via targeting Dlx5.","date":"2014","source":"Journal of cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/24733577","citation_count":32,"is_preprint":false},{"pmid":"15362572","id":"PMC_15362572","title":"Dlx5, the mouse homologue of the human-imprinted DLX5 gene, is biallelically expressed in the mouse brain.","date":"2004","source":"Journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/15362572","citation_count":31,"is_preprint":false},{"pmid":"12459268","id":"PMC_12459268","title":"An L1 element disrupts human bone sialoprotein promoter: lack of tissue-specific regulation by distalless5 (Dlx5) and runt homeodomain protein2 (Runx2)/core binding factor a1 (Cbfa1) elements.","date":"2002","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/12459268","citation_count":31,"is_preprint":false},{"pmid":"18316591","id":"PMC_18316591","title":"A novel recurrent chromosomal inversion implicates the homeobox gene Dlx5 in T-cell lymphomas from Lck-Akt2 transgenic mice.","date":"2008","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/18316591","citation_count":30,"is_preprint":false},{"pmid":"24496061","id":"PMC_24496061","title":"Exome sequencing reveals a heterozygous DLX5 mutation in a Chinese family with autosomal-dominant split-hand/foot malformation.","date":"2014","source":"European journal of human genetics : EJHG","url":"https://pubmed.ncbi.nlm.nih.gov/24496061","citation_count":30,"is_preprint":false},{"pmid":"27335460","id":"PMC_27335460","title":"Exclusion of Dlx5/6 expression from the distal-most mandibular arches enables BMP-mediated specification of the distal cap.","date":"2016","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/27335460","citation_count":30,"is_preprint":false},{"pmid":"32420617","id":"PMC_32420617","title":"LacZ-reporter mapping of Dlx5/6 expression and genoarchitectural analysis of the postnatal mouse prethalamus.","date":"2020","source":"The Journal of comparative neurology","url":"https://pubmed.ncbi.nlm.nih.gov/32420617","citation_count":29,"is_preprint":false},{"pmid":"20824629","id":"PMC_20824629","title":"Msx1 and Dlx5 function synergistically to regulate frontal bone development.","date":"2010","source":"Genesis (New York, N.Y. : 2000)","url":"https://pubmed.ncbi.nlm.nih.gov/20824629","citation_count":29,"is_preprint":false},{"pmid":"26512061","id":"PMC_26512061","title":"Dlx5 and Dlx6 control uterine adenogenesis during post-natal maturation: possible consequences for endometriosis.","date":"2015","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/26512061","citation_count":28,"is_preprint":false},{"pmid":"28982687","id":"PMC_28982687","title":"The Dlx5-FGF10 signaling cascade controls cranial neural crest and myoblast interaction during oropharyngeal patterning and development.","date":"2017","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/28982687","citation_count":28,"is_preprint":false},{"pmid":"23382810","id":"PMC_23382810","title":"BMP-mediated functional cooperation between Dlx5;Dlx6 and Msx1;Msx2 during mammalian limb development.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23382810","citation_count":28,"is_preprint":false},{"pmid":"14666512","id":"PMC_14666512","title":"Dlx5/6-enhancer directed expression of Cre recombinase in the pharyngeal arches and brain.","date":"2003","source":"Genesis (New York, N.Y. : 2000)","url":"https://pubmed.ncbi.nlm.nih.gov/14666512","citation_count":26,"is_preprint":false},{"pmid":"30429452","id":"PMC_30429452","title":"Inhibition of STAT5A promotes osteogenesis by DLX5 regulation.","date":"2018","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/30429452","citation_count":26,"is_preprint":false},{"pmid":"21227998","id":"PMC_21227998","title":"Identification of direct downstream targets of Dlx5 during early inner ear development.","date":"2011","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/21227998","citation_count":26,"is_preprint":false},{"pmid":"20014320","id":"PMC_20014320","title":"Polymethylmethacrylate particles impair osteoprogenitor viability and expression of osteogenic transcription factors Runx2, osterix, and Dlx5.","date":"2010","source":"Journal of orthopaedic research : official publication of the Orthopaedic Research Society","url":"https://pubmed.ncbi.nlm.nih.gov/20014320","citation_count":25,"is_preprint":false},{"pmid":"10474161","id":"PMC_10474161","title":"Dlx-5 in limb initiation in the chick embryo.","date":"1999","source":"Developmental dynamics : an official publication of the American Association of Anatomists","url":"https://pubmed.ncbi.nlm.nih.gov/10474161","citation_count":25,"is_preprint":false},{"pmid":"19195802","id":"PMC_19195802","title":"Expression analysis and mutation detection of DLX5 and DLX6 in autism.","date":"2009","source":"Brain & development","url":"https://pubmed.ncbi.nlm.nih.gov/19195802","citation_count":24,"is_preprint":false},{"pmid":"18498429","id":"PMC_18498429","title":"Isolation and imprinting analysis of the porcine DLX5 gene and its association with carcass traits.","date":"2008","source":"Animal genetics","url":"https://pubmed.ncbi.nlm.nih.gov/18498429","citation_count":23,"is_preprint":false},{"pmid":"17027239","id":"PMC_17027239","title":"Dlx5- and Dlx6-mediated chondrogenesis: Differential domain requirements for a conserved function.","date":"2006","source":"Mechanisms of development","url":"https://pubmed.ncbi.nlm.nih.gov/17027239","citation_count":23,"is_preprint":false},{"pmid":"34370013","id":"PMC_34370013","title":"Activation of bivalent factor DLX5 cooperates with master regulator TP63 to promote squamous cell carcinoma.","date":"2021","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/34370013","citation_count":23,"is_preprint":false},{"pmid":"37492739","id":"PMC_37492739","title":"DLX5 promotes Col10a1 expression and chondrocyte hypertrophy and is involved in osteoarthritis progression.","date":"2023","source":"Genes & diseases","url":"https://pubmed.ncbi.nlm.nih.gov/37492739","citation_count":22,"is_preprint":false},{"pmid":"25332435","id":"PMC_25332435","title":"Absent expression of the osteoblast-specific maternally imprinted genes, DLX5 and DLX6, causes split hand/split foot malformation type I.","date":"2014","source":"Journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/25332435","citation_count":22,"is_preprint":false},{"pmid":"33002480","id":"PMC_33002480","title":"RETRACTED: KDM4A promotes the growth of non-small cell lung cancer by mediating the expression of Myc via DLX5 through the Wnt/β-catenin signaling pathway.","date":"2020","source":"Life sciences","url":"https://pubmed.ncbi.nlm.nih.gov/33002480","citation_count":22,"is_preprint":false},{"pmid":"27645561","id":"PMC_27645561","title":"Transcriptome analysis of periodontitis-associated fibroblasts by CAGE sequencing identified DLX5 and RUNX2 long variant as novel regulators involved in periodontitis.","date":"2016","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/27645561","citation_count":21,"is_preprint":false},{"pmid":"29670900","id":"PMC_29670900","title":"T-614 Promotes Osteoblastic Cell Differentiation by Increasing Dlx5 Expression and Regulating the Activation of p38 and NF-κB.","date":"2018","source":"BioMed research international","url":"https://pubmed.ncbi.nlm.nih.gov/29670900","citation_count":20,"is_preprint":false},{"pmid":"19956613","id":"PMC_19956613","title":"Dlx5 Is a cell autonomous regulator of chondrocyte hypertrophy in mice and functionally substitutes for Dlx6 during endochondral ossification.","date":"2009","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/19956613","citation_count":20,"is_preprint":false},{"pmid":"25467232","id":"PMC_25467232","title":"BRONJ-related jaw bone is associated with increased Dlx-5 and suppressed osteopontin-implication in the site-specific alteration of angiogenesis and bone turnover by bisphosphonates.","date":"2014","source":"Clinical oral investigations","url":"https://pubmed.ncbi.nlm.nih.gov/25467232","citation_count":20,"is_preprint":false},{"pmid":"19393622","id":"PMC_19393622","title":"Calmodulin-dependent kinase II regulates Dlx5 during osteoblast differentiation.","date":"2009","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/19393622","citation_count":19,"is_preprint":false},{"pmid":"17969168","id":"PMC_17969168","title":"GAD isoforms exhibit distinct spatiotemporal expression patterns in the developing mouse lens: correlation with Dlx2 and Dlx5.","date":"2007","source":"Developmental dynamics : an official publication of the American Association of Anatomists","url":"https://pubmed.ncbi.nlm.nih.gov/17969168","citation_count":19,"is_preprint":false},{"pmid":"10330497","id":"PMC_10330497","title":"Expression of DLX5 during human embryonic craniofacial development.","date":"1999","source":"Mechanisms of development","url":"https://pubmed.ncbi.nlm.nih.gov/10330497","citation_count":18,"is_preprint":false},{"pmid":"24682237","id":"PMC_24682237","title":"Expression of GAD67 and Dlx5 in the taste buds of mice genetically lacking Mash1.","date":"2014","source":"Chemical senses","url":"https://pubmed.ncbi.nlm.nih.gov/24682237","citation_count":18,"is_preprint":false},{"pmid":"25196357","id":"PMC_25196357","title":"Heterozygous DLX5 nonsense mutation associated with isolated split-hand/foot malformation with reduced penetrance and variable expressivity in two unrelated families.","date":"2014","source":"Birth defects research. Part A, Clinical and molecular teratology","url":"https://pubmed.ncbi.nlm.nih.gov/25196357","citation_count":18,"is_preprint":false},{"pmid":"30657543","id":"PMC_30657543","title":"Down-regulation of miR-339 promotes differentiation of BMSCs and alleviates osteoporosis by targeting DLX5.","date":"2019","source":"European review for medical and pharmacological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/30657543","citation_count":18,"is_preprint":false},{"pmid":"29901112","id":"PMC_29901112","title":"miR‑339‑5p negatively regulates loureirin A‑induced hair follicle stem cell differentiation by targeting DLX5.","date":"2018","source":"Molecular medicine reports","url":"https://pubmed.ncbi.nlm.nih.gov/29901112","citation_count":18,"is_preprint":false},{"pmid":"30322210","id":"PMC_30322210","title":"cAMP/Protein Kinase A Signaling Inhibits Dlx5 Expression via Activation of CREB and Subsequent C/EBPβ Induction in 3T3-L1 Preadipocytes.","date":"2018","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/30322210","citation_count":17,"is_preprint":false},{"pmid":"29301908","id":"PMC_29301908","title":"Deletion of a Long-Range Dlx5 Enhancer Disrupts Inner Ear Development in Mice.","date":"2018","source":"Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/29301908","citation_count":17,"is_preprint":false},{"pmid":"22342398","id":"PMC_22342398","title":"Rapp-Hodgkin syndrome and SHFM1 patients: delineating the p63-Dlx5/Dlx6 pathway.","date":"2012","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/22342398","citation_count":17,"is_preprint":false},{"pmid":"21505076","id":"PMC_21505076","title":"Allelic reduction of Dlx5 and Dlx6 results in early follicular depletion: a new mouse model of primary ovarian insufficiency.","date":"2011","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/21505076","citation_count":17,"is_preprint":false},{"pmid":"30297736","id":"PMC_30297736","title":"Probing the origin of matching functional jaws: roles of Dlx5/6 in cranial neural crest cells.","date":"2018","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/30297736","citation_count":17,"is_preprint":false},{"pmid":"23933587","id":"PMC_23933587","title":"Endothelin regulates neural crest deployment and fate to form great vessels through Dlx5/Dlx6-independent mechanisms.","date":"2013","source":"Mechanisms of development","url":"https://pubmed.ncbi.nlm.nih.gov/23933587","citation_count":17,"is_preprint":false},{"pmid":"28674422","id":"PMC_28674422","title":"Increased methylation and decreased expression of homeobox genes TLX1, HOXA10 and DLX5 in human placenta are associated with trophoblast differentiation.","date":"2017","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/28674422","citation_count":16,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":52182,"output_tokens":10468,"usd":0.156783,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":20920,"output_tokens":4524,"usd":0.10885,"stage2_stop_reason":"end_turn"},"total_usd":0.265633,"stage1_batch_id":"msgbatch_01AsR7g8dGTEiEw9U83bJeWn","stage2_batch_id":"msgbatch_01YV5ZyxtFNUZEjxRcpd9jzb","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2004,\n      \"finding\": \"MeCP2 mediates formation of a silent-chromatin loop at the Dlx5-Dlx6 locus by recruiting histone deacetylase 1 and promoting repressive histone methylation at Lys9, thereby suppressing Dlx5 transcription; loss of MeCP2 abolishes this loop and increases Dlx5-Dlx6 expression approximately two-fold in mouse brain.\",\n      \"method\": \"Chromatin immunoprecipitation combined loop assays, ChIP for HDAC1 and H3K9 methylation, Mecp2-null mouse brains\",\n      \"journal\": \"Nature genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal ChIP-loop assays with multiple chromatin marks, validated in Mecp2-null mouse brain, multiple orthogonal methods in one study\",\n      \"pmids\": [\"15608638\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"Targeted null mutation of Dlx5 in mice causes craniofacial abnormalities (derivatives of branchial arches 1–4), severe malformations of the vestibular organ, delayed ossification of the skull roof, and abnormal osteogenesis, establishing independent roles for Dlx5 in branchial arch patterning, vestibular morphogenesis, and osteoblast differentiation.\",\n      \"method\": \"Gene targeting (Dlx5 null allele replacing exons I and II with lacZ), phenotypic analysis of homozygous mutant mice\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean loss-of-function with specific phenotypic readouts, independently replicated (PMID 10433912)\",\n      \"pmids\": [\"10433909\", \"10433912\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"BMP-2 specifically and immediately induces Dlx5 expression (independent of new protein synthesis), and Dlx5 is an indispensable upstream mediator of BMP-2-induced Runx2 expression and osteoblast differentiation; TGF-β1 opposes this pathway by inducing AP-1, which suppresses Dlx5 expression.\",\n      \"method\": \"Cycloheximide treatment, antisense Dlx5 blocking, overexpression assays in C2C12 cells, BMP-2/TGF-β1 treatment\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal approaches (cycloheximide, antisense, overexpression), replicated across subsequent studies\",\n      \"pmids\": [\"12815054\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"BMP-2-induced Osterix expression requires Dlx5 as an obligatory upstream mediator; antisense blocking of Dlx5 completely abrogates BMP-2-induced Osterix expression, whereas Runx2 overexpression alone is insufficient to induce Osterix in myogenic cells.\",\n      \"method\": \"Antisense Dlx5 blocking, Runx2 null cells, Runx2 overexpression in C2C12, BMP-2 treatment\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — antisense loss-of-function with defined molecular readout, replicated in subsequent study (PMID 18056716)\",\n      \"pmids\": [\"12963046\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Dlx5 binds to homeodomain sequences in the proximal Osterix promoter both in vitro and in vivo. Additionally, Dlx5 is a direct substrate of p38 MAPK, which phosphorylates Dlx5 at Ser-34 and Ser-217; this phosphorylation increases the transactivation potential of Dlx5 and enhances Osterix expression.\",\n      \"method\": \"In vitro kinase assay, in vivo phosphorylation assay, EMSA, ChIP, site-directed mutagenesis of phosphorylation sites, Dlx5 overexpression/knockdown\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro kinase assay plus mutagenesis of phosphorylation sites plus ChIP binding validation, single lab with multiple orthogonal methods\",\n      \"pmids\": [\"18056716\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Dlx5 specifically transactivates the Runx2 type II (P1 distal promoter) by directly binding to three homeodomain-response elements between -756 and -342 bp of the P1 promoter, as confirmed by gel mobility shift assay and site-directed mutagenesis; Msx2 antagonizes this by competing for the same elements.\",\n      \"method\": \"Runx2 promoter deletion analysis, gel mobility shift assay (EMSA), site-directed mutagenesis, overexpression of Dlx5 and Msx2, in situ hybridization in developing cranial vault\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — EMSA plus mutagenesis plus deletion analysis, single lab with multiple orthogonal methods\",\n      \"pmids\": [\"16115867\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Dlx5 directly binds to a cis-acting homeodomain element in the alkaline phosphatase (ALP) promoter to stimulate ALP expression independently of Runx2; Msx2 competes with Dlx5 for this same element to repress ALP transcription.\",\n      \"method\": \"EMSA, site-directed mutagenesis, ALP promoter reporter assays, Runx2-null cell studies, Dlx5/Msx2 overexpression\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — EMSA plus mutagenesis plus functional promoter assays, single lab with multiple orthogonal methods\",\n      \"pmids\": [\"15383550\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"Dlx5 reverses Msx2-mediated repression of the osteocalcin promoter by forming heterodimers with Msx2 via residues 127–143 of Dlx5; intrinsic DNA binding by Dlx5 is not required for this de-repression, which instead involves abrogating Msx2 inhibition of the OCFREB transcription factor.\",\n      \"method\": \"Far-Western blot (protein-protein interaction), transient cotransfection reporter assays, deletion/structure-function analysis, EMSA\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — far-Western direct binding plus mutagenesis plus functional reporter assays, single lab with multiple orthogonal methods\",\n      \"pmids\": [\"9819228\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Dlx5 interferes with the ability of Msx2 to interact with Runx2 and to repress Runx2 transcriptional activity; the craniosynostosis-associated Msx2 P148H mutant retains ability to bind and repress Runx2 but is resistant to Dlx5 regulation.\",\n      \"method\": \"Co-immunoprecipitation, transcriptional reporter assays, overexpression of Dlx5 and Msx2 mutants in C2C12 cells\",\n      \"journal\": \"Genes to cells : devoted to molecular & cellular mechanisms\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal Co-IP plus functional reporter assay, single lab\",\n      \"pmids\": [\"11683913\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Chromatin immunoprecipitation in osteoblasts revealed a sequential switch in homeodomain protein occupancy at the osteocalcin gene promoter: Msx2 occupies the repressed promoter in proliferating osteoblasts, then Dlx3 and Dlx5 are recruited postproliferatively to activate transcription, with Dlx5 occupancy increasing over Dlx3 at the mineralization stage; Dlx5 occupies the OC promoter coincident with increased RNA polymerase II.\",\n      \"method\": \"Chromatin immunoprecipitation (ChIP) assays, RNA interference knockdown of Dlx3, reporter assays, Dlx3-Runx2 protein-protein interaction mapping\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP assays with multiple antibodies plus RNAi plus protein interaction mapping, single lab with multiple orthogonal methods\",\n      \"pmids\": [\"15456894\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Dlxin-1, a novel MAGE/necdin-related protein, physically binds Dlx5 (also Dlx7 and Msx2) and activates the transcriptional function of Dlx5 in reporter assays.\",\n      \"method\": \"Yeast two-hybrid screening, GST pull-down, co-immunoprecipitation, reporter gene assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — yeast two-hybrid plus GST pulldown plus Co-IP plus functional reporter, single lab\",\n      \"pmids\": [\"11084035\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"The RING finger E3 ubiquitin ligase Praja1 binds Dlxin-1 (a Dlx5-interacting protein) and promotes its ubiquitin-dependent proteasomal degradation, thereby down-regulating Dlx5-dependent transcriptional activity; a RING finger mutant of Praja1 lacks these effects.\",\n      \"method\": \"Yeast two-hybrid, GST pull-down, co-immunoprecipitation, in vivo ubiquitination assay, proteasome inhibitor treatment, GAL4-dependent transcription reporter assay, RING finger mutagenesis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — in vivo ubiquitination assay plus domain mutagenesis plus multiple binding assays plus functional reporter, single lab with multiple orthogonal methods\",\n      \"pmids\": [\"11959851\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Combined targeted inactivation of Dlx5 and Dlx6 results in homeotic-like transformation of the lower jaw into an upper jaw structure, demonstrating that Dlx5/6 specify mandibular (lower jaw) identity in the first pharyngeal arch.\",\n      \"method\": \"Double knockout mice (Dlx5 and Dlx6 null alleles), skeletal morphological analysis\",\n      \"journal\": \"Genesis (New York, N.Y. : 2000)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean double loss-of-function with specific morphogenetic readout, replicated in subsequent studies\",\n      \"pmids\": [\"12434331\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Combined null mutation of Dlx5 and Dlx6 causes severe craniofacial, axial, and appendicular skeletal abnormalities including split-hand/split-foot malformation (ectrodactyly); transgenic overexpression of Dlx5 specifically in the apical ectodermal ridge of Dlx5/6 null mice fully rescues limb outgrowth defects.\",\n      \"method\": \"Double knockout mice, spatiotemporal transgenic rescue, skeletal analysis\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — double knockout plus transgenic rescue, clean epistasis, replicated findings\",\n      \"pmids\": [\"12000792\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Dlx5 is a positive regulator of chondrocyte maturation; retroviral misexpression of Dlx5 in the chick limb promotes conversion of immature proliferating chondrocytes into hypertrophying chondrocytes, expands type X collagen and osteopontin expression domains, and reduces chondrocyte proliferation.\",\n      \"method\": \"Retroviral misexpression in chick limb in vivo, histological analysis, molecular marker analysis (type X collagen, osteopontin)\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo retroviral gain-of-function with multiple molecular and histological readouts, consistent with Dlx5 null limb phenotype\",\n      \"pmids\": [\"12482714\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Dlx5 is a cell-autonomous regulator of chondrocyte hypertrophy; Col2a1-Dlx5 transgenic mice with Dlx5 restricted specifically to chondrocytes (not perichondrium) display accelerated hypertrophy and mineralization, and this transgene rescues chondrocyte differentiation defects in Dlx5/6 null mice.\",\n      \"method\": \"Chondrocyte-specific transgenic expression (Col2a1-Dlx5), rescue of Dlx5/6 null phenotype, histological analysis\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — cell-type-specific transgenic expression plus null rescue, establishes cell autonomy\",\n      \"pmids\": [\"19956613\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"The Dlx5 homeobox gene is essential for vestibular morphogenesis; Dlx5 null mice lack semicircular canals and show shortened endolymphatic duct, and this is accompanied by drastically reduced BMP4 expression in the otic vesicle, placing Bmp4 downstream of Dlx5 in the vestibular development pathway.\",\n      \"method\": \"Dlx5 null mouse analysis, in situ hybridization for Bmp4, Nkx5.1, Pax2, Lfng; immunostaining for sensory markers\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — loss-of-function with specific molecular pathway readout, replicated across two independent Dlx5 null studies\",\n      \"pmids\": [\"12142028\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Loss of either Dlx5 alone or Dlx5&6 together preferentially reduces the number of mature parvalbumin-positive cortical interneurons when mutant immature interneurons are transplanted into wild-type brains, demonstrating a cell-autonomous requirement for Dlx5 in development of parvalbumin-positive interneurons; remaining PV+ interneurons show increased dendritic branching.\",\n      \"method\": \"Cell transplantation of mutant immature interneurons into wild-type brain, conditional Dlx5/6 deletion, electrophysiology, immunohistochemistry for PV/calretinin/somatostatin\",\n      \"journal\": \"The Journal of neuroscience : the official journal of the Society for Neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — cell transplantation assay establishes cell autonomy with defined cellular phenotype\",\n      \"pmids\": [\"20392955\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"DLX5 directly binds the IRS-2 promoter and transcriptionally activates IRS-2, which in turn sustains AKT phosphorylation; stable knockdown of DLX5 reduces IRS-2 expression, decreases AKT signaling, and inhibits ovarian cancer cell proliferation, while constitutively active AKT rescues this effect.\",\n      \"method\": \"ChIP of DLX5 binding to IRS-2 promoter, shRNA knockdown, constitutively active AKT rescue, luciferase reporter assay, xenograft tumor assay\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP direct binding plus functional rescue experiments plus in vivo xenograft, single lab with multiple orthogonal methods\",\n      \"pmids\": [\"21045156\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"DLX5 directly binds two sites in the MYC promoter (shown by EMSA and ChIP) and transcriptionally activates MYC in a dose-dependent manner; knockdown of DLX5 in lung cancer cells reduces MYC expression and proliferation, which is rescued by MYC overexpression.\",\n      \"method\": \"Luciferase promoter assay, EMSA, ChIP, DLX5 overexpression/knockdown, rescue by MYC overexpression\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — EMSA plus ChIP plus functional rescue, single lab with multiple orthogonal methods\",\n      \"pmids\": [\"19497851\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Loss of Dlx5 in the olfactory epithelium results in olfactory receptor neurons that form normally but fail to generate axons that innervate the olfactory bulb; additionally, Dlx5 has a cell-autonomous effect on neural progenitor ability to produce olfactory bulb local circuit neurons (granule cells more severely affected than periglomerular cells).\",\n      \"method\": \"Dlx5 null mouse analysis, transplantation of Dlx5-/- olfactory bulbs into wild-type neonates, histological and immunochemical characterization\",\n      \"journal\": \"The Journal of neuroscience : the official journal of the Society for Neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — transplantation assay establishes cell autonomy, clean loss-of-function with specific cellular readouts\",\n      \"pmids\": [\"12533617\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Dlx5 null osteoblasts show reduced proliferation and differentiation, reduced Runx2/Osx/Osteocalcin/Bone Sialoprotein expression, and a higher RANKL/OPG ratio; Dlx5-/- osteoblasts induce greater osteoclast formation in spleen cultures, establishing that Dlx5-expressing osteoblasts indirectly control osteoclast activity (osteoblast-osteoclast coupling).\",\n      \"method\": \"Dlx5 null mouse embryo femur analysis, osteoblast culture, spleen co-culture osteoclast assay, RANKL/OPG expression measurement\",\n      \"journal\": \"The American journal of pathology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — loss-of-function with multiple molecular and cellular readouts plus ex vivo functional assay\",\n      \"pmids\": [\"18669617\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Calmodulin-dependent kinase II (CaMKII) phosphorylates Dlx5, increases Dlx5 protein stability, and enhances its osteoblastogenic transactivation activity; conversely, the CaMKII inhibitor KN-93 decreases osteogenic and transactivation activities of Dlx5.\",\n      \"method\": \"In vitro kinase assay, co-transfection with CaMKII, reporter assay, CaMKII inhibitor (KN-93) treatment\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1-2 / Weak — in vitro kinase assay plus functional reporter, single lab, single paper\",\n      \"pmids\": [\"19393622\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"A highly conserved intergenic enhancer (I56i) between Dlx5 and Dlx6 is activated by DLX proteins binding directly to it; Dlx1/2 mutant mice show drastically reduced enhancer activity and reduced Dlx5/6 expression, establishing a cross-regulatory loop where Dlx1/2 drive Dlx5/6 expression through this enhancer.\",\n      \"method\": \"Reporter transgene in transgenic mice and zebrafish, cotransfection assays, DNA-protein binding experiments, analysis in Dlx1/2 double mutant mice\",\n      \"journal\": \"The Journal of neuroscience : the official journal of the Society for Neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — transgenic reporter in two species plus direct DNA-protein binding plus genetic epistasis in Dlx1/2 null mice\",\n      \"pmids\": [\"10632600\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Dlx5 and Mef2c directly bind a 343-bp osteoblast-specific enhancer ~30 kb upstream of the Runx2 distal promoter; mutation of their binding sites abolishes osteoblast-specific Runx2 enhancer activity in vivo, while other factors (Tcf7, Ctnnb1, Sp7, Smad1, Sox6) are recruited via protein-protein interaction to form an enhanceosome.\",\n      \"method\": \"BAC-GFP reporter mice, serial deletion analysis, ChIP in primary osteoblasts, histone modification analysis, mutagenesis of binding sites in transgenic mice\",\n      \"journal\": \"Journal of bone and mineral research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — ChIP plus in vivo binding site mutagenesis in transgenic mice, multiple orthogonal methods\",\n      \"pmids\": [\"24692107\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Dlx5 directly promotes transcription of Fgf7 in palatal mesenchyme; loss of Dlx5 leads to Fgf7 downregulation and expanded Shh signaling to the nasal side, while exogenous Fgf7 inhibits Shh signaling and reverses CNC cell proliferation rescue in Msx1/Dlx5 double knockout palates.\",\n      \"method\": \"Dlx5 null mice, Msx1/Dlx5 double knockout mice, exogenous Fgf7 treatment of palatal mesenchyme cultures, Shh expression analysis\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — double knockout epistasis plus rescue experiment, single lab\",\n      \"pmids\": [\"19934017\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Hand2 establishes a negative-feedback loop in the distal mandibular arch: Dlx5/6 induce Hand2, and Hand2 subsequently represses Dlx5/6 expression in distal arch ectomesenchyme; failure to repress Dlx5/6 results in upregulation of Runx2, aberrant bone formation, and failure of tongue morphogenesis (aglossia).\",\n      \"method\": \"Hand2 conditional knockout mice, in situ hybridization for Dlx5/6/Hand2/Runx2, histological analysis of mandibular arch\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — conditional knockout with defined epistasis (Dlx5/6→Hand2→Dlx5/6 negative feedback), multiple molecular readouts\",\n      \"pmids\": [\"21558373\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"DLX5 targets the FGF8 locus directly and activates FGF8 expression; FGF8 in turn counteracts Pin1-ΔNp63α interaction, preventing Pin1-mediated proteasomal degradation of p63; p63 SHFM/EEC mutant proteins are resistant to Pin1 action, establishing a DLX5-FGF8-Pin1-p63 regulatory loop in AER stratification.\",\n      \"method\": \"ChIP for DLX5 binding at FGF8 locus, in vitro Pin1-p63 interaction assays, Pin1 null mouse analysis, proteasome inhibitor studies, SHFM/EEC p63 mutant analysis\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP plus in vitro interaction plus mutant protein analysis, single lab\",\n      \"pmids\": [\"24569166\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Chromatin immunoprecipitation confirmed that Dlx5 directly binds the promoters of at least seven genes in the inner ear (Atbf1, Bmper, Large, Lrrtm1, Msx1, Ebf1, and Lhx1), with Bmper and Lrrtm1 upregulated by Dlx5 overexpression, placing Bmp signaling downstream of Dlx5 in the inner ear.\",\n      \"method\": \"Gene expression profiling of WT vs. Dlx5 null otic vesicles, ChIP with Dlx5 antibody in Dlx5-overexpressing cell line, bioinformatic promoter analysis\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP confirming direct binding plus expression change in overexpression cell line, single lab\",\n      \"pmids\": [\"21227998\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Neural stem cells from Dlx5-null newborn mice have severely reduced capacity to generate neurons in vitro; forced re-expression of Dlx5 in mutant NSCs fully restores neuronogenic potential, demonstrating a cell-autonomous requirement for Dlx5 in postnatal neurogenesis.\",\n      \"method\": \"Neural stem cell cultures from Dlx5 null mice, forced Dlx5 expression rescue, differentiation assays\",\n      \"journal\": \"Molecular and cellular neurosciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — loss-of-function plus rescue in defined cell culture system, single lab\",\n      \"pmids\": [\"14962748\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"AMPK activation (via metformin/AICAR) stimulates osteoblast differentiation through a Smad1/5/8-Dlx5-Runx2 signaling cascade; siRNA knockdown of Dlx5 suppresses metformin-induced Runx2 expression, and dominant-negative AMPK blocks Dlx5 induction.\",\n      \"method\": \"AMPK activators/inhibitors, DN-AMPK expression, Dlx5 siRNA knockdown, Runx2-Luc reporter assay, BRE-Luc reporter assay\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — siRNA plus reporter assays plus pharmacological epistasis, single lab, single paper\",\n      \"pmids\": [\"21187071\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"STAT5A negatively regulates Dlx5 expression; STAT5A deletion in mice results in increased trabecular and cortical bone mass, enhanced Dlx5 levels, and increased osteogenesis of BMSCs, with prevention of age-related bone loss.\",\n      \"method\": \"STAT5A conditional knockout mice, siRNA knockdown of STAT5A in hBMSCs, in vivo fracture model, micro-CT bone analysis\",\n      \"journal\": \"Cell death & disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo knockout plus in vitro knockdown with defined molecular and phenotypic readouts, single lab\",\n      \"pmids\": [\"30429452\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"cAMP/PKA signaling suppresses Dlx5 transcription via sequential activation of CREB and then C/EBPβ; C/EBPβ directly binds a specific site (-517 to -510 bp, site-1) in the Dlx5 promoter to repress its transcription during adipogenic differentiation.\",\n      \"method\": \"cAMP/PKA activators, forced CREB and C/EBPβ expression, siRNA knockdown of C/EBPβ, luciferase promoter assays, ChIP for C/EBPβ at Dlx5 promoter\",\n      \"journal\": \"International journal of molecular sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP confirming direct binding plus promoter mutagenesis plus epistasis experiments, single lab\",\n      \"pmids\": [\"30322210\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Dlx5 and Dlx6 regulate Msx2 expression cell-autonomously in AER cells and limb mesoderm; in the anterior limb mesoderm, a non-cell-autonomous Msx-Dlx regulatory loop involves BMP molecules through the AER; ChIP analysis confirmed Dlx5/6 regulatory interactions at the Msx2 locus.\",\n      \"method\": \"Triple knockout mice (Msx1/Dlx5/Dlx6 and Msx2/Dlx5/Dlx6), qPCR, ChIP, bioinformatic analysis\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP plus triple-mutant genetic epistasis, single lab\",\n      \"pmids\": [\"23382810\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Dlx5 in CNC cells regulates FGF10 pathway activity; loss of Dlx5 reduces FGF10 signaling and leads to altered proliferation/apoptosis of CNC and muscle progenitor cells in the soft palate; activation of FGF10 signaling rescues CNC cell proliferation and myogenic differentiation in Dlx5 mutant mice.\",\n      \"method\": \"Dlx5 conditional knockout in NCCs (Wnt1-Cre), FGF10 pathway analysis, exogenous FGF10 rescue experiment, lineage tracing\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — conditional knockout plus rescue experiment, single lab with defined molecular pathway\",\n      \"pmids\": [\"28982687\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"DLX5 cooperates with TP63 to regulate ~2000 enhancers and promoters in squamous cell carcinoma; DLX5 transcriptional activation is directly mediated by SOX2 at the bivalent DLX5 promoter; DLX5 silencing substantially inhibits SCC cell viability in vitro and in vivo.\",\n      \"method\": \"ELMER computational analysis, ChIP-seq for DLX5 and TP63, SOX2 ChIP, shRNA knockdown in vitro and xenograft in vivo, bisulfite sequencing for promoter methylation\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP-seq plus functional knockdown in vitro and in vivo, single lab\",\n      \"pmids\": [\"34370013\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"DLX5 directly binds the Col10a1 cis-enhancer to promote Col10a1 transcription and chondrocyte hypertrophy; forced DLX5 expression in hypertrophic chondrocytes upregulates RUNX2, suggesting cooperative regulation of Col10a1 by DLX5 and RUNX2 through adjacent binding sites on the enhancer.\",\n      \"method\": \"Dual-luciferase reporter assay, ChIP assay with DLX5 antibody, Dlx5 overexpression and knockdown in MCT and ATDC5 cells, murine OA model\",\n      \"journal\": \"Genes & diseases\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP confirming direct binding plus luciferase assay plus gain/loss-of-function, single lab\",\n      \"pmids\": [\"37492739\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"An alternative Dlx5 transcript (deltaDlx5) encodes a truncated protein lacking the homeodomain; unlike full-length DLX5, deltaDLX5 is deficient in DNA-binding activity and does not interact with the homeoprotein partner MSX1.\",\n      \"method\": \"RT-PCR cloning, in vitro DNA-binding assay, co-immunoprecipitation/interaction assays\",\n      \"journal\": \"The Journal of neuroscience : the official journal of the Society for Neuroscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — direct comparison of protein activities, single lab, single paper\",\n      \"pmids\": [\"9763476\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"DLX5 and HOXC8 form a protein complex and co-operatively repress LINC01013 lncRNA by directly binding its promoter (ChIP-confirmed); DLX5/HOXC8-mediated repression of LINC01013 enhances chondrogenic differentiation of stem cells from apical papilla.\",\n      \"method\": \"Co-immunoprecipitation for DLX5-HOXC8 complex, ChIP assay for promoter binding, LINC01013 knockdown, pellet culture and in vivo cartilage defect model\",\n      \"journal\": \"Stem cell research & therapy\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP plus ChIP plus functional in vivo rescue, single lab\",\n      \"pmids\": [\"32631410\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Allelic reduction of Dlx5 and Dlx6 in mouse ovary results in POI-like phenotype with reduced fertility and early follicular exhaustion; a reciprocal regulation exists between Dlx5/6 and Foxl2 in granulosa cells, and Dlx5/6 reduction leads to upregulation of Foxl2, with both factors having opposing effects on StAR expression.\",\n      \"method\": \"Dlx5/6 hypomorph mice, granulosa cell line transfection, StAR and Foxl2 expression analysis\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — genetic model plus cell line transfection, single lab, single paper\",\n      \"pmids\": [\"21505076\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Dlx5 is expressed by olfactory receptor neurons and controls miR-9 and miR-200 class miRNA levels in the olfactory epithelium; in zebrafish, depletion of miR-9 and miR-200 causes delayed ORN differentiation, altered axonal targeting, and altered GnRH neuron genesis, with miR-9/-200 negatively controlling Foxg1 mRNA.\",\n      \"method\": \"miRNA expression profiling in Dlx5 null olfactory epithelium, miR-9/200 morpholino depletion in zebrafish reporter embryos, foxg1 mRNA overexpression in zebrafish\",\n      \"journal\": \"Molecular and cellular neurosciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — loss-of-function in mouse plus functional validation in zebrafish, two organisms, single lab\",\n      \"pmids\": [\"25937343\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"A single nucleotide polymorphism in the ultraconserved Dlx5/6 intergenic enhancer I56i (found in an autistic proband) reduces DLX protein binding affinity in vitro and reduces transcriptional activation of the enhancer by Dlx proteins; affinity purification identified GTF2I as a novel regulator binding the I56i element.\",\n      \"method\": \"Transgenic enhancer reporter mice, in vitro DNA-protein binding affinity assay, affinity purification, electrophoretic mobility shift assay\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — transgenic reporter plus in vitro binding plus affinity purification, single lab\",\n      \"pmids\": [\"20702565\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"DLX5 is a homeodomain transcription factor that functions as a central regulator of osteoblast, chondrocyte, neural, and craniofacial development: it is directly induced by BMP-2 signaling (immediately, without requiring new protein synthesis) and acts upstream of Runx2 type II (via direct binding to P1 promoter homeodomain elements), Osterix (via direct binding to the Osterix proximal promoter), and alkaline phosphatase (via a cis-acting homeodomain element in the ALP promoter); its transcriptional activity is modulated post-translationally by p38 MAPK phosphorylation at Ser-34/Ser-217 (enhancing activity) and by CaMKII phosphorylation (increasing protein stability and transactivation); it forms inhibitory heterodimers with MSX2 (requiring residues 127–143) to relieve MSX2 repression of osteocalcin transcription; the Dlxin-1 co-activator and the E3 ubiquitin ligase Praja1 (which degrades Dlxin-1) further tune DLX5 transcriptional output; in the nervous system, DLX5 is required cell-autonomously for parvalbumin-positive cortical interneuron development and postnatal neurogenesis; in jaw development, DLX5/6 specify mandibular identity in neural crest cells and are themselves regulated by a Hand2 negative-feedback loop; DLX5 drives MYC and IRS-2 transcription in cancer contexts; and long-range cis-regulatory enhancers (including sequences within and near DYNC1I1) control tissue-specific DLX5 expression, with disruption of these enhancers underlying split-hand/foot malformation.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"DLX5 is a homeodomain transcription factor that serves as a central effector of skeletal, craniofacial, and neural development, transducing BMP signaling into osteogenic and patterning gene programs [#2, #1]. In the osteoblast lineage, BMP-2 immediately and protein-synthesis-independently induces Dlx5, which acts as an obligatory upstream mediator of both Runx2 and Osterix and is itself required for osteoblast differentiation [#2, #3]. DLX5 exerts this control by directly binding homeodomain elements: three response elements in the Runx2 type II (P1) promoter, the proximal Osterix promoter, a cis-element in the alkaline phosphatase promoter, and an osteoblast-specific Runx2 enhancer where it cooperates with Mef2c to nucleate an enhanceosome [#5, #4, #6, #24]. At the osteocalcin promoter DLX5 antagonizes MSX2-mediated repression, both by competing for shared homeodomain elements and by forming inhibitory heterodimers with MSX2 through residues 127\\u2013143, and a developmental switch recruits DLX5 to activate the gene postproliferatively [#5, #6, #7, #9]. DLX5 transcriptional output is tuned post-translationally by p38 MAPK phosphorylation at Ser-34/Ser-217 and by CaMKII, which enhance transactivation and stability, and by the Dlxin-1 co-activator whose abundance is controlled by the E3 ligase Praja1 [#4, #22, #10, #11]. In craniofacial development DLX5/6 specify mandibular identity, regulate chondrocyte hypertrophy cell-autonomously, and operate within Hand2 negative-feedback and FGF-mediated mesenchymal circuits [#12, #15, #26, #34]. Long-range DLX5/6 intergenic enhancers (I56i) are bound and cross-activated by DLX proteins, and combined Dlx5/6 loss produces split-hand/split-foot malformation with limb defects rescuable by AER-restricted Dlx5 [#23, #13]. In the nervous system DLX5 is cell-autonomously required for parvalbumin-positive cortical interneuron development, postnatal neurogenesis, and olfactory neuron axon targeting [#17, #29, #20]. In cancer, DLX5 directly activates MYC and IRS-2 to drive proliferation and AKT signaling [#19, #18].\",\n  \"teleology\": [\n    {\n      \"year\": 1998,\n      \"claim\": \"Established that DLX5 functions partly through protein-protein interaction rather than solely DNA binding, by showing it heterodimerizes with MSX2 to relieve repression of osteocalcin.\",\n      \"evidence\": \"Far-Western, deletion/structure-function mapping and reporter assays identifying residues 127\\u2013143\",\n      \"pmids\": [\"9819228\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not map the MSX2 interaction surface\", \"OCFREB de-repression mechanism not structurally defined\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Defined the in vivo requirement for Dlx5, showing it is independently needed for branchial arch patterning, vestibular morphogenesis, and osteoblast differentiation.\",\n      \"evidence\": \"Dlx5-null mouse with phenotypic analysis, independently replicated\",\n      \"pmids\": [\"10433909\", \"10433912\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not identify direct transcriptional targets underlying each phenotype\", \"Functional redundancy with Dlx6 not resolved\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Placed Dlx5/6 at the top of jaw and limb identity programs through combinatorial loss-of-function and spatially restricted rescue.\",\n      \"evidence\": \"Dlx5/6 double-knockout mice with mandibular-to-maxillary transformation and AER-restricted transgenic rescue of limb defects\",\n      \"pmids\": [\"12434331\", \"12000792\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct targets specifying mandibular identity not enumerated\", \"Mechanism of split-hand/foot phenotype not molecularly resolved here\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Identified Dlx5 as the indispensable, immediate BMP-2 effector upstream of both Runx2 and Osterix, ordering the osteogenic transcription cascade.\",\n      \"evidence\": \"Cycloheximide, antisense Dlx5 blocking and overexpression in C2C12 cells with BMP-2/TGF-\\u03b21 treatment\",\n      \"pmids\": [\"12815054\", \"12963046\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not show direct promoter binding (addressed later)\", \"Mechanism of immediate BMP-2 induction of Dlx5 not defined\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Demonstrated direct, sequence-specific DLX5 transactivation of Runx2 type II and competitive antagonism by MSX2, providing the cis-regulatory basis for the cascade.\",\n      \"evidence\": \"Runx2 promoter deletion, EMSA, site-directed mutagenesis of three homeodomain elements, Dlx5/Msx2 overexpression\",\n      \"pmids\": [\"16115867\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo enhancer context not tested here (later addressed)\", \"Stoichiometry of Dlx5/Msx2 competition not quantified\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Showed that DLX5 osteogenic activity is gated by signaling, with p38 MAPK directly phosphorylating Ser-34/Ser-217 to boost transactivation and Osterix expression.\",\n      \"evidence\": \"In vitro/in vivo kinase assays, phosphosite mutagenesis, EMSA and ChIP at Osterix promoter\",\n      \"pmids\": [\"18056716\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural consequence of phosphorylation not defined\", \"Whether CaMKII and p38 act on same residues unknown\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Revealed a co-activator/degradation module tuning DLX5 output via Dlxin-1 and its turnover, and a chromatin-level repression mechanism at the locus via MeCP2.\",\n      \"evidence\": \"Y2H/GST/Co-IP and ubiquitination assays for Dlxin-1\\u2013Praja1; ChIP-loop assays for MeCP2/HDAC1/H3K9me at the Dlx5\\u2013Dlx6 locus in Mecp2-null brain\",\n      \"pmids\": [\"11084035\", \"11959851\", \"15608638\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Physiological contexts where Dlxin-1/Praja1 set DLX5 levels not defined\", \"Whether MeCP2 silencing operates outside brain unknown\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Resolved DLX5 as a Runx2-independent activator of differentiation markers and established its cell-autonomous role in postnatal neurogenesis.\",\n      \"evidence\": \"EMSA/mutagenesis at the ALP promoter in Runx2-null cells; Dlx5-null neural stem cell cultures with re-expression rescue\",\n      \"pmids\": [\"15383550\", \"14962748\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Downstream neuronal differentiation targets of DLX5 not identified\", \"ALP activation cofactors not defined\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Extended DLX5 function to interneuron specification and cancer, showing cell-autonomous control of parvalbumin interneurons and direct activation of MYC and IRS-2 in tumors.\",\n      \"evidence\": \"Interneuron transplantation/conditional deletion; EMSA/ChIP and rescue for MYC (lung) and IRS-2/AKT (ovarian) in tumor models\",\n      \"pmids\": [\"20392955\", \"19497851\", \"21045156\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How DLX5 is reactivated in cancer not defined here\", \"Interneuron target genes not identified\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Established the in vivo enhanceosome basis of DLX5-driven osteoblast Runx2 expression and connected DLX5 to AER stratification through an FGF8-Pin1-p63 loop.\",\n      \"evidence\": \"BAC-GFP reporter mice with binding-site mutagenesis (Dlx5/Mef2c Runx2 enhancer); ChIP and Pin1/p63 interaction analysis for FGF8 loop\",\n      \"pmids\": [\"24692107\", \"24569166\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Order of enhanceosome assembly not resolved\", \"FGF8-Pin1-p63 loop is single-lab Medium evidence\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Defined the Hand2 negative-feedback architecture and FGF-mediated mesenchymal circuits through which Dlx5 patterns the mandibular arch and palate.\",\n      \"evidence\": \"Conditional knockouts and double-knockout epistasis with Fgf7/Fgf10/Shh rescue experiments\",\n      \"pmids\": [\"21558373\", \"19934017\", \"28982687\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct vs indirect regulation of some FGF ligands not fully separated\", \"Single-lab epistasis for several circuits\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Identified upstream repressive inputs (STAT5A, cAMP/PKA-CREB-C/EBP\\u03b2) that set Dlx5 levels and bias osteogenic vs adipogenic fate.\",\n      \"evidence\": \"STAT5A knockout/knockdown with micro-CT; cAMP/PKA epistasis with ChIP for C/EBP\\u03b2 at the Dlx5 promoter\",\n      \"pmids\": [\"30429452\", \"30322210\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single-lab studies\", \"Integration of multiple repressive inputs not modeled\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Showed DLX5 acts within a TP63/SOX2 oncogenic enhancer network in squamous cell carcinoma, broadening its cancer role beyond single-gene activation.\",\n      \"evidence\": \"ChIP-seq for DLX5/TP63, SOX2 ChIP, bisulfite sequencing, and shRNA knockdown in vitro and in xenografts\",\n      \"pmids\": [\"34370013\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single-lab study\", \"Mechanism coupling SOX2-driven DLX5 to specific oncogenic outputs not fully defined\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How DLX5's distinct post-translational modifications, cofactor states, and partner choices are integrated to select among osteogenic, chondrogenic, neural, and oncogenic gene programs in a given cell remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No unified model linking phosphorylation state to target selectivity\", \"Genome-wide DLX5 occupancy compared across tissues not established\", \"Structural basis of MSX2/HOXC8 heterodimer specificity unknown\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [2, 5, 18, 19, 24]},\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [4, 5, 6, 19, 28]},\n      {\"term_id\": \"GO:0003700\", \"supporting_discovery_ids\": [5, 6]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [4, 5, 9]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [1, 12, 13, 14]},\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [5, 6, 18, 19, 24]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [2, 3, 4, 22]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [13, 18, 19, 35]}\n    ],\n    \"complexes\": [\"Runx2 osteoblast enhanceosome (Dlx5/Mef2c)\"],\n    \"partners\": [\"MSX2\", \"MEF2C\", \"Dlxin-1\", \"HOXC8\", \"TP63\", \"MSX1\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":9,"faith_total":9,"faith_pct":100.0}}